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 ABSTRACT 
 
The regulation of pulmonary blood flow and ventilation during exercise is 
mediated by numerous factors, yet the role of certain cardiovascular and 
pulmonary reflex control systems is unknown. Therefore this thesis investigated 
the pulmonary vascular response to the activation of the muscle metaboreflex 
alone, and combined with activation of the muscle mechanoreflex. The 
ventilatory responses to the activation of the muscle metaboreflex were also 
studied under a background of activated ventilatory chemoreceptors. Finally the 
effect of increased metabolism on the ventilatory sensitivity to carbon dioxide 
was investigated in healthy humans. We found that activation of the muscle 
metaboreflex induced pulmonary vasoconstriction that was alleviated by muscle 
mechanoreflex activation. Furthermore a respiratory response to the activation of 
the muscle metaboreflex was observed in hypercapnia but not when breathing 
room air. Finally we found that increases in metabolic rate induced elevations in 
the ventilatory sensitivity to carbon dioxide. Overall these data suggest that the 
interplay between cardiovascular and respiratory control systems contribute to 
the regulation of pulmonary haemodynamics and breathing during exercise. Our 
findings could be implicated in the reduced exercise tolerance seen in chronic 
heart failure patients. 
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Ach = acetylcholine 
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ANS = autonomic nervous system 
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MAP = mean atrial pressure 
MR = metabolic rate  
MVC = maximum voluntary contraction 
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PAP = mean pulmonary artery pressure 
PAO2 = partial pressure of arterial oxygen 
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PECO = post-exercise circulatory occlusion 
PETCO2 = partial pressure of end-tidal carbon dioxide  
PETO2  = partial pressure of end-tidal oxygen 
PVP = mean pulmonary venous pressure  
PVR = pulmonary vascular resistance 
PWD = pulsed wave Doppler 
Q˙   = cardiac output 
RAP = right atrial pressure 
RQ = respiratory quotient 
SAP = systolic arterial pressure 
SBRS = spontaneous baroreflex sensitivity 
SEM = standard error of mean 
SNS = sympathetic nervous system 
SPAP = systolic pulmonary artery pressure 
STP = short-term potentiation 
STPD = standard temperature and pressure 
SV = stroke volume 
V?A = alveolar ventilation 
VE = pulmonary ventilation 
VHS= video home system 
VO2 = oxygen consumption 
VCO2 = carbon dioxide production 
VTI = velocity-time integral 
ΔPMAX = maximum transtricuspid pressure difference 
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CHAPTER 1: 
INTRODUCTION 
 
 1
In the healthy state, performance of exercise induces a variety of physiological 
adjustments, which aim to satisfy the increased need for oxygen and 
metabolic substrates by the musculature, and to maintain an optimal 
environment for the functioning of other systems in the human body. Broadly 
these adjustments include increases in ventilation, cardiac output, pulmonary 
and active muscle blood flow, and reductions in blood flow towards vascular 
beds that are not actively involved in exercise. Central command and reflex 
control systems represent the two main pathways, which are involved in the 
mediation of these adjustments. Of paramount importance are the redundancy 
and complex relationships that exist between the aforementioned mediators of 
the exercise responses.  
The pulmonary system plays a fundamental part in the adjustments taking 
place during exercise as it facilitates oxygenation of mixed venous blood and 
its provision to the left heart while ensuring the maintenance of an optimal 
acid-base status. However, despite vast amount of research, there are still 
areas concerning the regulation of pulmonary blood flow and ventilation during 
exercise that are not clear. Existing gaps in knowledge have presented a 
burden in the understanding of the reduced exercise capacity of patients with 
chronic heart disease, which is increasingly prevalent in modern societies. 
Fortunately, recent technological advances have allowed for an extended 
scope of measurements to be performed, thereby improving knowledge on 
physiological functioning.    
The first part of this introduction will firstly provide a brief account of the basic 
aspects of respiratory physiology and anatomy. Particular attention will be 
given to the regulation of pulmonary blood flow at rest and during exercise in 
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the healthy and heart failure states. In the second part, the mechanisms 
mediating the regulation of ventilation at rest and during exercise in the 
healthy and heart failure states will be outlined. Special mention will be paid to 
the carotid body as a respiratory controller. The third part of the introduction 
will briefly portray the role of the muscle reflexes in the cardiovascular control 
during exercise and in parallel conclude the background needed for the 
experimental chapters, which will be outlined in the fourth part of this 
introduction. 
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Part 1. RESPIRATORY PHYSIOLOGY AND REGULATION OF 
PULMONARY BLOOD FLOW AT REST AND EXERCISE 
  
1.1: BASIC RESPIRATORY PHYSIOLOGY AND ANATOMY 
 
The lungs constitute an interface between the environment and the 
cardiovascular system. Their prime function is to allow oxygen from the 
inspired air to move into venous blood, and expel the carbon dioxide from 
mixed venous blood into the atmosphere. Given the continuous need of 
tissues in the human body for oxygen, right ventricular output passes through 
the lungs during each circulation, ensuring constant re-oxygenation of the 
venous blood. Importantly, the ‘branching tree’ design of the main functional 
components of the lungs, airways and blood vessels, allows fast and efficient 
gas exchange to occur between blood and air both at rest and during 
exercise, when systemic oxygen consumption may be very high.   
 
1.1.1: Airways 
Atmospheric air enters from the nose and mouth and flows into the conductive 
portion of the respiratory system as negative pressure is generated by the 
expansion of the chest and the contraction of the diaphragm. At this stage 
inspired air is adjusted to body temperature, filtered and humidified as it 
passes through the trachea, which represents the first part of the airway 
‘branching tree’ organisation. The inspired air passes into the two branches of 
the trachea, namely the right and left bronchi, which then split into five 
branches, known as the lobar bronchi. This dividing process continues down 
to the terminal bronchioles, which complete the conductive part of the 
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respiratory system. The collective volume of the conductive part 
(approximately 150 mL in adults) is known as the anatomical dead space, 
since no gas exchange takes place in it. Subsequently, the respiratory zone, 
in which gas exchange occurs, begins with the respiratory bronchioli which 
branch from the terminal bronchioli. Respiratory bronchioli have occasional 
alveoli attached on their walls, and give rise to alveolar ducts, which are 
completely lined up with alveoli (West, 1995). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Schematic representation of the 
structure of the bronchial tree. (Adapted from 
West, 1995). 
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1.1.2: Diffusion 
The movement of oxygen and carbon dioxide across the blood/gas barrier 
constitutes one fundamental process of breathing, known as diffusion. 
Diffusion refers to the passive movement of molecules across a membrane 
and along a concentration gradient and is described by Fick’s law. Therefore, 
according to Fick, the rate of diffusion is proportional to the area of the 
membrane, the gas partial pressure difference between the two sides of the 
membrane, and a diffusion constant that is directly proportional to the 
solubility of a gas in the membrane, but inversely proportional to the square 
root of its molecular weight. The rate of diffusion is inversely proportional to 
the thickness of the membrane. Fick’s law of diffusion is written as: 
)P(P
T
ADV 21gas −⋅⋅=&  
where V˙  gas is the diffusion rate, D is the diffusion constant, A is the area over 
which a gas diffuses, T is the thickness of the barrier, and (P1–P2) is the 
partial pressure difference of the gas across the barrier. 
 
Diffusion is promoted by the enormous area that the blood/gas barrier covers 
and also by its thickness, which can be as low as 0.3 μm in some places. The 
pressure gradient for oxygen and carbon dioxide across the blood/gas barrier 
(I.e. between alveolar gas and pulmonary arterial blood) is about 60 mmHg 
(100 alveolar – 40 venous) and 5 mmHg (45 venous – 40 alveolar) 
respectively. The low-pressure gradient for carbon dioxide is immensely 
counterbalanced by its superior solubility to oxygen facilitating a diffusion rate 
20 times faster compared to that of oxygen.  
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Diffusion rates for either gas are more than adequate in facilitating rapid gas 
exchange. Therefore, the alveolar and arterial gas partial pressures between 
the alveolus and the capillary equilibrate within about 0.25 seconds while a 
red blood cell takes approximately 0.75 seconds to move through the 
capillary. This is quite important during exercise when blood flow through the 
lungs increases dramatically (up to 20-fold) and the red blood cells have 
substantially less time crossing the alveoli in order for O2 and CO2 partial 
pressures to reach equilibrium (West, 1995). 
 
 
 
1.2: THE PULMONARY CIRCULATION 
 
1.2.1: Anatomy and function 
The function of the pulmonary circulation is to deliver poorly oxygenated blood 
at the gas exchange surface and to deliver it to the left heart in order to be 
distributed throughout the body. Therefore, it commences at the main 
pulmonary artery, which receives deoxygenated blood from the right heart, 
and then successively branches into smaller arteries accompanying the 
pattern of the bronchial tree. This branching pattern ends at the level of the 
terminal bronchioles where the arteries break up and form an exceptionally 
dense network of capillaries that lies in the alveolar walls. After the blood 
becomes oxygenated it is collected by the small pulmonary veins that run into 
the capillary bed. Small pulmonary veins unite to form the four large veins 
from which blood drains into the left atrium. 
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The contraction of the right ventricle drives an amount of blood into the 
pulmonary circulation (right ventricular output) that is almost equal to that 
entering the systemic circulation due to left ventricular contraction (left 
ventricular output). The aorta distributes blood throughout a number of smaller 
circulations (i.e. renal, intestinal, brain, kidneys and muscles), which can self-
regulate blood flow according to the metabolic demands of the organ they 
perfuse. The pulmonary circulation in turn, which is continuously receiving the 
entire right ventricular output, presents a higher degree of distensibility than 
that of the systemic circulation due to the fact that pulmonary arteries have 
thinner walls and less smooth muscle relative to the systemic ones (Nunn, 
2000; West, 1995).  
 
 
1.2.2: Blood pressure and resistance to blood flow in the pulmonary circulation 
Owing to its high distensibility, the large cumulative cross-sectional area and 
diffusion barrier, the pulmonary circulation operates under lower pressures as 
compared with the systemic circulation. Therefore the mean pulmonary artery 
pressure is about 15 mmHg (25/8 mmHg; systolic vs diastolic) and much 
lower than its systemic counterpart which is about 100 mmHg (120/80 mmHg; 
systolic vs diastolic). In addition, the driving pressure (difference between 
input and output) in the pulmonary circulation is ten times lower compared to 
that in the systemic circulation.  
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Pulmonary vascular resistance (PVR) refers to the resistance to flow across 
lungs and is defined as the ratio between driving pressure across the lungs 
and flow. 
Q
PVP - PAP  PVR &=    
where PAP is mean pulmonary artery pressure, PVP is mean pulmonary 
venous pressure, and Q˙   is volume (cardiac output). The pulmonary circulation 
can accommodate large increases in blood flow (i.e. cardiac output) without 
excessive increases in pulmonary artery pressure, implying that pulmonary 
vascular resistance decreases with elevations in cardiac output. This property 
of the pulmonary circulation is attributed to the high distensibity of the 
vasculature and to the fact that high blood flow force open arteries from 
previously under-perfused areas of the lungs. The latter functional 
characteristic is known as recruitment (Naeije, 2000; West, 1995). 
 
1.2.3: Blood flow distribution 
Owing to the low resistance in the pulmonary circulation, the distribution of 
blood in the lungs is greatly affected by gravity. Therefore the lower parts of 
the lungs are greatly perfused yet blood flow is diminished as the distance 
from the base of the lung increases. West et al (1964) proposed that the lung 
is divided in three vertical zones based upon the pressure in the alveoli, the 
arteries and the veins (figure 1.1).  
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Figure 1.2: Left: The three zones of the lung incorporating the Starling resistor 
model for each zone inside the outline of the lung. Middle: relationship of 
pulmonary artery pressure (PA), pulmonary vein pressure (PV), and alveolar 
pressure (Pa) for each of the three zones. Right: graph of distance up the lung 
versus blood flow (Adapted from West et al., 1964). 
 
 
 
Zone 1 resides at the top of the lung (apex) and receives little blood flow. In 
this zone, alveolar pressure (PA) exceeds both arterial pressure (Pa) and 
venous pressure (Pv). As such, the higher pressure in the alveoli collapses the 
vessels enabling little or no flow through. In Zone 2, which is at the middle 
section of the lung, alveolar pressure is lower than arterial pressure and 
higher than venous pressure. Blood flow in zone 2 is mediated by the 
alveolar-arterial pressure difference as venous pressure is less than alveolar 
pressure. The greater the arterial pressure, the wider the vessel will open 
thereby facilitating an enhanced blood flow. Recruitment of previously 
collapsed vessels also contributes to the increases in blood flow in this zone.  
 10
Zone 3 resides at the bottom part of the lung where arterial pressure is greater 
than venous pressure, and both are greater than alveolar pressure. Given 
this, the flow in zone 3 is regulated by the arterial-venous pressure difference. 
Increases in blood flow are mediated mainly by distension of the arteries 
(West, 1964; 1995). The relationship between distance from the base of the 
lung and blood flow is diagrammatically shown in figure 1.2. Notably, flow at 
the very bottom of the lung is reduced compared to the area that resides five 
centimetres higher. The decreased blood flow through this area, which is 
sometimes called Zone 4, is thought to be due to the compression of extra-
alveolar vessels by hydrostatic pressure (West, 1995). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Graph showing how blood flow is reduced as distance from the 
bottom of the lung increases. Also shown is the reduction of blood flow at the 
very bottom of the lung (zone 4). (Adapted from West, 1995). 
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1.2.4: Control of the pulmonary vasculature; tone and resistance 
The pulmonary circulation is a high-flow and low-resistance circuit that 
accommodates the right ventricular output at about 20% of the systemic 
pressure. The fundamental difference between the pulmonary and the 
systemic circulations is that the latter is regulated primarily by neural and 
humoral (active) mechanisms whereas the in the former passive mechanisms 
predominate (Barnes & Liu 1995). 
 
 
 
Passive mechanisms 
 
As it has been mentioned previously, cardiac output exerts a great influence 
on PVR and it can be summarised as follows. Elevations in cardiac output 
lead to increases in pulmonary vascular pressures and in turn in the radius of 
the pulmonary vessels, given their high distensibilty. High blood pressures in 
the pulmonary circuit will also open and perfuse previously collapsed vessels. 
Consequently pulmonary vascular pressure will decrease. The opposite 
effects are seen upon decreases in cardiac output (Dawson et al., 1989; 
Grover et al., 1985; Hakim et al., 1989; Naeije, 2000). Moreover, fluctuations 
in left atrial pressure will be transmitted to pulmonary artery pressure thereby 
influencing resistance. Alternatively, left atrial pressure is a determinant of the 
downstream pressure in the pulmonary circuit (i.e. PVP), which in turn is a 
determinant of PVR by definition (Kuramoto & Rodbard, 1962). Systemic 
arterial pressure can also influence pulmonary haemodynamics via its effects 
on pulmonary blood flow, left ventricular emptying and left atrial pressure 
(Reeves et al., 1996)  
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As it was mentioned previously resistance in the pulmonary circulation is 
influenced by gravity both in a direct and an indirect fashion since not only it 
alters the distribution of blood in lungs but can also affect cardiac output 
(Dawson et al., 1989; Grover et al., 1985; Naeije, 2000). Lung volume 
represents another passive factor that affects PVR. Therefore at functional 
residual capacity (i.e. at the end of a passive expiration), resistance is minimal 
yet above it resistance dramatically increases due to narrowing of alveolar 
capillaries caused by expansion of alveoli (Culver & Butler, 1980).    
 
 
Active mechanisms 
Factors that actively regulate the tone and thus resistance in the pulmonary 
circuit can be classified into three main categories; chemical, humonal and 
neural.  
 
Chemical control 
It is well known that levels of oxygen and carbon dioxide in the alveoli and in 
mixed venous blood exert a great influence on pulmonary vascular tone. 
Therefore vasoconstriction in veins and arteries has been well documented in 
response to decreased levels of oxygen (hypoxia) in various animal 
preparations (Brashers et al., 1988; Hillier et al., 1997; Madden et al., 1985) 
as well as in intact animals (Barer et al., 1970) and humans (Dorrington et al., 
1997). In fact, hypoxic pulmonary vasoconstriction represents a physiological 
response of small arteries (200-600 μm internal diameter) that diverts mixed 
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venous blood away from hypoxic alveoli. This is known to optimise the 
matching between ventilation and perfusion thereby preventing arterial 
hypoxemia (Olschewski & Weir, 2000; Shirai et al., 1986). Hypoxic pulmonary 
vasoconstriction is known to be intrinsic to the lung and has been suggested 
to be mediated by an elevation of Ca2+ in arterial smooth muscle that results 
in the.opening of voltage-gated Ca2+ channels and myocyte contraction 
(Aaronson et al., 2006; Olschewski & Weir, 2000). Despite intensive research, 
the signalling pathways that lead to this cascade of events have yet to be 
precisely clarified. A number of authors have suggested that Ca2+ release 
from the sarcoplasmic reticulum occurs secondary to hypoxia-induced 
increases in cyclic ADP-ribose (Wilson et al., 2001). Others have proposed 
that hypoxia induces changes in levels of H2O2 and other reactive oxygen 
species that lead to an inhibition of voltage-gated K+ channels and cell 
depolarisation (Moudgil et al., 2005). Increased levels of oxygen or hyperoxia 
are known to produce vasodilation and its degree could be dependent on the 
pre-existing tone (Fishman, 1990; Fineman et al., 1993).  
Blood acidity as well as levels of carbon dioxide and in both inspirate and 
blood also mediate changes in vascular tone, with hypercapnia (increased 
levels) and hypocapnia (decreased levels) inducing vasoconstriction and 
vasodilation, respectively (Kiely et al., 1996). It is generally accepted that 
hypercapnia and hypocapnia exert their effects via the concomitant changes 
to pH. Interestingly it is known that both hyperoxia and hypocapnia attenuate 
the vascular responses to vasoconstrictor stimuli, which are enhanced by both 
hypoxia and hypercapnia (Archer et al., 1989; Archer & Michelakis, 2002; 
Barnes & Liu, 1996; Dawson, 1984; Olschewski & Weir, 2000).  
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Humoral control 
Several mediators and hormones can have an effect on pulmonary vascular 
tone that is mediated via multiple receptors (Table 1.1). Substances that affect 
tone in the pulmonary vasculature include catecholamines, eicosanoids, 
amines, peptides, and purine nucleosides, and their effects can vary 
depending on the species tested, age and the pre-existing tone. Despite 
intensive research, the physiological role of humoral control has not been 
clearly elucidated (Barnes & Liu, 1996; Bergofsky, 1980; Dawson, 1984). It 
has been suggested that maintenance of low pulmonary tone is a result of a 
balance between vasodilators and vasoconstrictors and that hormones could 
play a part in this phenomenon (Barnes & Liu, 1996). Coupled to that, it has 
been postulated that the influence of hormones on pulmonary vascular tone 
can be greater in course of physiological adaptations such as pregnancy, 
exercise and cold exposure (Moore, 1989). On more firm grounds is the 
hormonal involvement in the pulmonary vascular abnormalities seen in 
various diseases. Therefore cyclo-oxygenase and lipoxygenase products 
have been known to mediate the pulmonary hypertension seen in adult 
respiratory distress syndrome (Rounds, 1989). In addition catecholamines 
have been suggested to play a role in pulmonary hypertension associated to 
chronic lung disease (Andreas et al., 2005; Salvi, 1999).    
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Table 1.1: Humoral receptors in pulmonary vessels. (Adapted from Barnes & 
Liu, 1996). 
 
Receptors Subtype Response  
Endothelium 
dependency 
Adenosine A1 Contraction No 
 A2 Relaxation No 
Angiotensin AT Contraction No 
ANP ANPA Relaxation No 
 ANPB Relaxation No 
Bradykinin B1 Relaxation Yes 
 B2 Relaxation Yes 
Endothelin ETA Contraction No 
 ETB Relaxation Yes 
Histamine H1 Relaxation Yes 
 H2 Relaxation No 
5-HT 5-HT1 Contraction No 
 5-HT1C Relaxation Yes 
Thromboxane TP Contraction No 
Vasopressin V1 Relaxation Yes 
 
 
Neural control: Basic functional anatomy  
Similarly to that for the hormonal control, the exact physiological role of neural 
mechanisms on pulmonary vascular tone and resistance has not been 
adequately defined. The pulmonary circulation receives both sympathetic and 
parasympathetic afferent and efferent nerve supply that is sparse relative to 
the systemic vasculature. The density of innervation is greater in the larger 
elastic arteries, less in the veins and muscular arteries, whereas vessels 
narrower than 30 μm does not receive nerve supply (Downing & Lee, 1980; 
Richardson, 1979; Spencer & Leof, 1964). Despite the sparse innervation 
pulmonary vascular tone is regulated by multiple autonomic receptors (Table 
1.2). 
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Sympathetic influence  
Stimulation of β2 adrenergic receptors has been unequivocally shown to 
mediate vasodilation (Hyman et al., 1981; Murray et al., 1986). On the 
contrary variable (up to 70%) increases in PVR have been seen in response 
to stellate ganglia (Daly, 1961; Daly et al., 1970; Duke et al., 1960; Ingram et 
al., 1970; Kadowitz et al., 1974; Kadowitz & Hyman, 1973; Szidon & Fishman, 
1971) or α-sympathetic stimulation in animal preparations (Barman, 1995; 
Murray et al., 1986; Piene, 1976). Whereas the degree of vascular 
responsiveness has been suggested to depend on the strength of sympathetic 
stimulation (i.e. stimulation frequency), a number of studies have reported 
increased arterial stiffness (Ingram et al., 1968; Szidon & Fishman, 1971) 
and/or increased pulmonary vascular impedance (Piene, 1976; Reuben et al., 
1971) in response to low-level sympathetic stimulation. Impedance, which can 
be defined as the ratio of the amplitude of oscillatory pressure to that of 
oscillatory flow at a given frequency, refers to the opposition to pulsatile flow 
from the right ventricle into the pulmonary circuit (Dawson et al., 1989; Piene 
1986). Thus it incorporates all the factors that oppose ventricular ejection such 
as the resistive, compliant, inertial and the pulse wave reflection properties of 
the vascular bed (Piene 1986) and therefore it has been widely suggested as 
a determinant of right ventricular work (Dawson et al., 1989; Grant & Lieber, 
1996; Piene, 1986).  
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Table 1.2: Autonomic receptors in pulmonary vessels. (Modified from Barnes 
& Liu,1996). 
 
Receptors Subtype Response  
Adrenergic α1 Contraction 
 α2 Contraction 
 β2 Relaxation 
Muscarinic M1 Relaxation 
 M3 relaxation/contraction
Purinergic P2X Contraction 
 P2Y Relaxation 
Tachykinin NK1 Relaxation 
 NK2 Contraction 
VIP n/a Relaxation 
CGRP n/a Relaxation 
 
 
Parasympathetic influence 
The cholinergic innervation of the pulmonary circulation is less intense as 
compared to that of the sympathetic nervous system. Likewise, the effects of 
parasympathetic nervous system on pulmonary vasculature have not been 
clearly identified partially due to the confounding role of the cardiovascular 
changes that accompany alterations in parasympathetic activity. Therefore, 
vagal withdrawal and activation are associated with cardiac output increases 
and decreases, respectively that can influence pulmonary vascular tone. In 
addition, studies on the effects of acetylcholine (Ach) on the pulmonary 
vascular circuit have produced mixed results, with vasodilation (Cherry & 
Gillis, 1987; Wilson et al., 1995), vasoconstriction (Chand & Altura, 1980; El-
Kashef et al., 1991) and a dual response (Altiere et al., 1986) being reported. 
A number of studies revealed that the initial vascular tone dictated the 
pulmonary vascular response to parasympathetic stimulation or inhibition. 
Therefore infusion of acetylcholine in either isolated vessels, lungs or in the 
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pulmonary circulation of the intact animal caused vasoconstriction when the 
initial tone was low and vasodilation when the pre-existing tone was high 
(Hyman et al., 1988; Hyman & Kadowitz, 1989; Vanhoutte, 1974). Notably all 
vascular responses to Ach were blocked by the muscarinic inhibitor atropine. 
In humans, studies on the parasympathetic influence on pulmonary 
vasculature and haemodynamics have been limited. Acetylcholine failed to 
affect pulmonary artery pressure at rest (Harris, 1957), whereas the effects of 
atropine were variable with both unaffected and mildly decreased pulmonary 
vascular resistance being reported at rest and during exercise (Daly et al., 
1963; Williams et al., 1960).   
 
 
1.3: PULMONARY CIRCULATION AND HAEMODYNAMICS DURING 
EXERCISE 
 
1.3.1: Basic overview 
During exercise, cardiac output and hence blood flow through the pulmonary 
circulation increases four-fold above resting levels, allowing for a greater 
uptake of oxygen and output of carbon dioxide. The increase in blood flow is 
facilitated through elevations of vascular driving pressure (pulmonary artery 
pressure minus pulmonary venous pressure) from the pulmonary artery to the 
left atrium and also due to the fact that pulmonary vascular resistance remains 
unchanged or decreases (Reeves et al., 1996).  
It is imperative that increases in driving pressure are not excessive as this will 
impose a great stress to the right ventricle and it will also induce severe 
impairments in gas exchange through fluid leakage into the alveoli. The latter 
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phenomenon can be observed during intense and/or unaccustomed exercise 
at high altitude (high altitude pulmonary oedema; HAPO) (Bärtsch et al., 
2002).  
 
1.3.2: Pulmonary haemodynamics 
The changes seen in vascular driving pressure have been traditionally thought 
to be largely the result of the increases seen in left atrial pressure (LAP). 
Elevations in LAP that have been ascribed to the Frank-Starling mechanism, 
pericardial limitation of ventricular filling and tachycardia-related limitations of 
diastolic filling time, are transmitted backwards into the pulmonary circulation, 
thereby increasing pulmonary venous and artery pressures (Reeves et al., 
1990; 1996). In addition, it has been suggested that LAP increases account 
for up to 80% of the variation in the pulmonary arterial pressure (Eldridge et 
al., 1996; Reeves et al., 1996). However, increases in vascular driving 
pressure are not always accompanied by increases in LAP, which could 
remain unchanged or even decrease during exercise (Luepker et al., 1971; 
Reeves et al., 1996). As such, it has been postulated that pulmonary artery 
pressure increases during exercise might be also related to other factors such 
as the degree of vascular distension arising from elevations in pulmonary 
blood flow (Banchero et al., 1966). Supporting the view that left heart 
haemodynamics might not be always dictating the pulmonary vascular 
response to exercise, Bernheim et al (2007) showed that the exaggerated 
increases in systolic pulmonary artery pressure during normoxic exercise 
seen in HAPO-susceptible individuals compared to controls were not related 
to Doppler-derived indices of left ventricular filling pressure. Interestingly, 
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higher levels of sympathetic activity were observed in HAPO-susceptible 
individuals, and consequently they have been suggested to contribute to the 
excessive pulmonary vascular pressure response to exercise resembling 
neurogenic pulmonary oedema (Bärtsch et al., 2005).    
Increases in PVR during exercise have been also observed in HAPO-
susceptible individuals (Kawashima et al., 1989), although decreases have 
been also reported (Eldridge et al., 1996). The course of PVR decreases 
during exercise in normal humans is known to depend on the body posture 
assumed. Therefore PVR declines gradually as intensity increases during 
supine exercise whereas, in the upright exercising person, there is a dramatic 
reduction in PVR during the transition from rest to mild workloads (Figure 1.3). 
The pronounced decrease in the upright position has been ascribed to 
recruitment of previously unperfused vessels at zone 1 and 2 yet this 
suggestion has not been universally acceptable. Vessel distension has been 
suggested to play a more important role in PVR reductions seen during supine 
exercise (Reeves et al., 1996). Recently, it has been postulated that active 
decreases in vascular tone could contribute to PVR response to exercise 
(Merkus et al., 2008), yet evidence to support this suggestion is inconclusive. 
In fact, several animal studies have shown that the interaction between 
vasodilatory and vasoconstrictive influences taking place during exercise has 
a neutral effect on the pulmonary circulation (Kane et al., 1993; 1994a;b; 
Koizumi et al., 1996). 
 
 
 Figure 1.4: Mean driving pressure (solid lines) and pulmonary vascular resistance (dashed lines) variations 
with cardiac output during supine (left panel) and upright (right panel) exercise. (pooled data from Reeves et 
al., 1996)   
21
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1.3.3: Pulmonary haemodynamics during exercise in cardiopulmonary disease 
It has been established that pulmonary haemodynamic response to exercise 
in chronic heart failure (Butler et al., 1999) is characterised by excessive 
increases in PAP and dampened decreases or even increases in PVR (Butler 
et al., 1999; Christensen et al., 2004; Janicki et al., 1985). This in turn has 
been associated to the excessive ventilatory exercise response and limited 
exercise tolerance in these patients (Reindl et al., 1998). It has been thought 
that the mechanisms underlying the abnormal haemodynamic responses to 
exercise are multiple and depend on the underlying pathology (Fink et al., 
1986). Increased stiffness of pulmonary vasculature is a common pathological 
feature in chronic lung and heart disease that could contribute to the 
increased pulmonary pressures seen during exercise (Berger et al., 2002; 
Merkus et al., 2008; Milnor et al, 1969; Reuben, 1971; Scrijen et al., 1982). 
Interestingly, the increased sympathetic activation represents a hallmark of 
these conditions (Andreas et al., 2005; Cohn et al., 1984) and could be 
involved in the abnormal pulmonary haemodynamics and inefficient ventilation 
during exercise through influencing the vasculature.  
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Part 2. REGULATION OF VENTILATION AT REST AND 
EXERCISE 
 
 
Breathing is a fundamental homeostatic behaviour that aims to oxygenate and 
remove carbon dioxide from, mixed venous blood while maintaining the 
arterial PO2, PCO2 and pH within a narrow range, at levels compatible with 
effective cell function (Bell, 2006; Ward, 2004). The precise match of 
respiration to the metabolic needs of the tissues involves integrative 
functioning of respiratory controllers, receptors and effectors. 
  
1.4: RESPIRATORY CONTROLLERS: CHARACTERISTICS AND 
LOCALISATION 
 
Breathing is controlled by respiratory neurons located within the lower 
brainstem that are involved in the creation and preservation of respiratory 
rhythm, the processing and integration of sensory inputs and the relay of 
synaptic signals to the respiratory effectors. The respiratory neurones are 
synaptically-networked and are categorised according to their pattern and 
time of discharge in relation to phrenic nerve activity into the following neuron 
groups; pre-inspiratory, early-inspiratory, inspiratory, late-inspiratory, post-
inspiratory and expiratory.  
Respiratory neurons are also classified according to their location within the 
lower brainstem into neurons of the pontine, dorsal and ventral respiratory 
group. Pontine respiratory neurons are involved in the control of inspiratory 
duration and in modulation of breathing frequency. The dostral respiratory 
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group is located in the nucleus tractus solitarius, which has connections with 
pontine respiratory neurons and receives input from baro-, mechano- and 
metaboreceptors. Finally, the ventral respiratory group, which incorporates the 
pre-Bötzinger and Bötzinger complex, the para-facial respiratory group and 
the upper cervical respiratory neurons, is involved in both inspiration and 
expiration (Cohen, 1979; Mateike& Duffin, 1995; Von Euler, 1997) (Figure 
1.5). 
 
 
 
Figure 1.5: Central respiratory controllers. A schematic representation of the 
location of the main groups of respiratory neurons and associated structures 
in the feline medulla and spinal cord. PRG; pontine respiratory group, Böt C; 
Bötzinger complex, DRG; dorsal respiratory group, VRG ventral respiratory 
group, UCIN upper cervical inspiratory neurons. (Modified from Mateika & 
Duffin, 1995). 
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Generation of respiratory rhythm and respiratory neural plasticity 
In contrast to the great amount of knowledge that has been accumulated on 
the control of inspiration and expiration, the neural structures responsible for 
respiratory rhythmogenesis have been less clearly identified. Therefore a 
number of theories have been proposed. It has been suggested that the 
respiratory rhythm is composed of three phases (inspiratory, post-inspiratory 
and expiratory) that arise from an interaction between respiratory neurons 
(Onimaru et al., 2000; Paton & Richter, 1995). Others argued for existence of 
a pacemaker originating from either the pre- Bötzinger complex or the para-
facial respiratory group (Butera et al., 1999; Onimaru & Homma, 2003). It has 
been also postulated that respiratory rhythmogenesis could be the result of 
the combined action of the aforementioned mechanisms (Richter et al., 1986; 
Ward, 2004). 
It has been established that the respiratory response to various challenges 
such as hypoxia / hypercapnia, exercise and injury is also modulated based 
on prior experience. This phenomenon, which is known as respiratory 
plasticity, involves a persistent change in the morphology and function of the 
neural control system. Two different time domains of respiratory plasticity 
have been identified; short- and long-term plasticity. The former domain 
accounts for the elevated ventilation seen after the exercise stimulus is 
removed. The latter refers to the persistent augmentation of the exercise 
ventilatory response seen after repeated bouts of exercise are performed with 
increased external dead space (Mitchell & Babb, 2006; Mitchell & Johnson 
2002). 
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1.5: RESPIRATORY EFFECTOR MUSCLES  
The term respiratory effectors encompasses various ‘pump’ and assessory 
muscle groups whose periodic contractions collectively results in intrathoracic 
pressure changes, exchange of air between the environment and the lungs 
and ultimately ventilation. The respiratory effectors contract in a coordinated 
manner under the directives of the respiratory controller motor outflow and 
produce two distinct ventilatory phases; inspiration and expiration. 
 
Diaphragm muscle and abdominal wall muscles  
The diaphragm, which plays a fundamental role in inspiration, consists of a 
large, dome-shaped thin sheet of muscle and fiber that provides a separation 
of the abdominal and thoracic cavities. Upon contraction, the diaphragm 
forces the abdominal contents downward and the ribs to be lifted and moved 
out thereby elongating and enlarging the chest cavity. This results in 
development of negative intrathoracic pressure, as compared to atmospheric 
pressure facilitating the inflation of lungs with air. In tidal breathing at rest the 
level of diaphragm movement is approximately 1 cm whereas with exercise 
and especially forced breathing the excursion can reach up to 10 cm. 
Relaxation of the diaphragm at tidal breathing shortens the thoracic cavity and 
in concert with the lung elastic recoil drives air out of the lungs (West, 1995). 
The abdominal wall muscle group, which comprises the rectus abdominus, 
internal and external oblique and transversus abdominus muscles, plays an 
important part in the increases in expiratory rates taking place during exercise. 
As these muscles contract they push the diaphragm and abdominal muscles 
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upward facilitating an increase in intra-abdominal pressure and assisting in 
expiration (Campbell & Green, 1955; West, 1995). 
 
Intercostal and accessory muscles  
Intercostal muscles, which are divided into external and internal, are known to 
be involved in both inspiration and expiration. As such, the external 
intercostals muscles connect adjacent ribs and they cause the ribs to be 
pulled upward and forward when they contract, increasing the dimensions of 
the thorax. The internal intercostals exert an opposite action to that of the 
external as they pull the ribs downward and inward thereby assisting active 
expiration. It should be stressed however that the contribution of the 
intercostal muscles in inspiration and expiration is far more complicated than 
that described in this brief account (De Troyer et al., 2005). 
The accessory muscles comprise the scalenes and the sternomastoids which 
upon contraction they elevate the first two ribs and the sternum, respectively. 
These muscles have been known to assist inspiration at rest, during heavy 
breathing and exercise (De Troyer & Estene, 1984; Hudson et al., 2007; 
Legrand et al., 2003; Ward, 1995). 
 
1.6: RESPIRATORY RECEPTORS 
Various inputs to the respiratory control centres are projected from various 
receptors including these within the upper airways, the lungs, the trachea, the 
bronchial tree, the muscles and joints involved in respiration as well as in the 
brainstem and the carotid bodies. Appropriate levels of respiration and hence 
maintenance of the arterial blood composition within suitable limits is the end-
 28
result of complex interaction between the effects mediated from activation of 
respiratory receptors and various other receptors that feed in respiratory 
control centres or adjacent structures.  
     
1.6.1: Upper airway receptors 
These receptors, which are located in the nasal passages, pharynx, larynx 
and the upper portion of the trachea, respond to mechanical and chemical 
stimuli. They serve to protect and defend the lower respiratory tract by 
initiating reflexes such as sniffing, sneezing and coughing (West, 1995). 
 
1.6.2: Lung, tracheal and bronchial receptors 
Various receptors are spread in the lungs and the tracheobronchial tree 
initiating regulatory and defence reflexes. Therefore the slowly adapting 
pulmonary stretch receptors are located in the airway smooth muscle and they 
provide information on the degree of lung inflation, an inspiratory off-switch 
and they are also responsible for the Hering-Beuer reflex. The latter refers to 
the inhibition of inspiration resulting from overinflation-mediated activation of 
the pulmonary stretch receptors. Signals from these receptors are transmitted 
to the brain via the vagus nerve at a maintained discharge rate in response to 
lung inflation (slow adaptation).  
The rapidly adapting pulmonary receptors are found between epithelial cells in 
the airways and they convey impulses to the brain via the vagus nerve. These 
receptors, which are activated by deleterious gases, dust, cold air and 
changes in lung compliance, are involved in pulmonary congestion, 
microembolisms and in asthmatic attacks.  
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The juxta-capillary receptors are located in the alveolar walls in close 
proximity to the capillaries and they are stimulated by increases in the volume 
of interstitial fluid at the alveolar walls inducing rapid, shallow breathing and 
apnoea.  
A number of nerve endings from C-fibers terminate in the walls of the trachea 
and bronchi and they are activated by pulmonary venous congestion and 
increases in lung stiffness. They have been proposed to be involved in the 
cough reflex. 
Juxta-capillary receptors or J-receptors, are believed to be located in the 
alveolar walls in close proximity to the capillaries. They are involved in the 
dyspnoea sensation associated with heart failure and lung disease (West, 
1995).  
 
1.6.3: Chemoreceptors 
Receptors sensitive to changes in the blood content of oxygen and carbon 
dioxide and blood acidity are known to play an important part in the interplay 
of adjusting breathing according to the metabolic needs of the body while 
maintaining the levels of oxygen, carbon dioxide and H+ in the blood within a 
narrow range. These receptors have been classified to central and peripheral 
owing to the localisation in the brain and the periphery, respectively.  
 
1.6.3.1: Central chemoreceptors 
Various sites in the brain that have been known to be sensitive to 
distrurbances in the partial pressure of carbon dioxide and acidity in 
cerebrospinal fluid are capable of modulating changes in ventilation. It has 
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been established that such receptors exist on the rostral and ventral area of 
the ventral medullary surface (Bruce & Cherniack, 1987; Lahiri & Forster, 
2007). Additional sites of central chemoreception can be found in the dorsal 
and ventral respiratory groups, in the locus coeruleus (Putnam et al., 2004), 
the NTS (Nattie & Li, 2002), retrotrapezoid nucleus (Li & Nattie, 1997; 
Takakura et al., 2006) and in the medullary raphė (Wang et al., 2001).  
It has been suggested that the process involved in central chemoreception 
most likely involves sensing of H+, whereas CO2 acts through its hydration to 
H+ and HCO3- (Lahiri & Forster, 2003). As carbon dioxide diffuses across the 
blood-brain barrier, the acidity of the cerebrospinal fluid bathing the 
chemosensitive parts of the brain changes according to the disturbances in 
the partial pressure of carbon dioxide and acidity of arterial blood. The time 
constant for ventilatory increases due to activation of central chemoreceptors 
by hypercapnia is known to lie between 65-180 seconds in humans (Tansley 
et al., 1998).  This wide variation could be due to the different employed 
methodologies and also to the influence of peripheral chemoreception and 
particular of the carotid body, which is known to play a part in modulating the 
central chemoresponsiveness to carbon dioxide (Dahan et al., 1990; 2007). 
 
1.6.3.2: Peripheral chemoreceptors 
It is well known that the rapid responses to respiratory stimuli, such as 
disturbances in O2 and CO2, tension are mediated by peripheral 
chemoreceptors, which have been identified at multiple extracranial sites 
including the aortic arch, abdomen and the carotid body. It has been widely 
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argued that the most important role in peripheral chemoreception is being 
played by the carotid body (Prabhakar & Peng, 2004). 
 
1.6.3.3: Other receptors 
Various other control systems, which provide neural input to respiratory 
centres, are known to influence ventilation. Therefore aortic and carotid sinus 
baroreceptors, which relay arterial blood pressure changes in the NTS, can 
either inhibit or enhance ventilation the central and peripheral drive to breathe 
(Heistad et al., 1974; Somers et al., 1991). Likewise, stimulation of pain 
(Borgbjerk et al., 1996) and thermal receptors is also known to be capable of 
inducing changes in ventilation. Finally muscle afferents sensitive to 
mechanical deformation and/or metabolites have been long thought to 
contribute to the increases in ventilation seen during exercise. A thorough 
account of these receptors’ involvement in the mediation of exercise 
hyperpnoea is taken place in the subsequent part of this introduction. 
 
Figure 1.6: Types of respiratory receptors. 
 32
1.7: THE CAROTID BODY 
 
1.7.1: Functions, basic histology and anatomy 
 
The carotid body is a small organ located bilaterally at the bifurcation of the 
carotid artery that is sensitive to a variety of chemical and physical stimuli. 
These include perturbations in oxygen, carbon dioxide, pH, blood pressure, 
temperature, K+, osmolarity, glucose, catecholamines and other hormones 
and substances (Gonzalez et al., 1994; Marshall, 1994).  This organ primarily 
serves to assess the composition of arterial blood before it reaches the brain 
and initiate reflex ventilatory responses in order to maintain the composition of 
arterial blood within suitable limits (Nye, 1993). In parallel, it has established 
that the carotid body plays an important role in neuroendocrine and 
haemodynamic regulation in response to a variety of stimuli such as hypoxia, 
hypercapnia and exercise (Kara et al., 2003; Koyama et al., 2001; Marshall, 
1994). Recent work on rats has also provided evidence for metabolic rate 
sensing by the carotid body (Bin Jaliah et al., 2004; 2005) that, in addition, 
has been heavily implicated in the abnormal cardiovascular and respiratory 
status of various diseases (Di Vanna et al., 2007; Kara et al., 2003; Stickland 
et al., 2007). 
The carotid body is a high-vascularised organ that receives the greatest rate 
of perfusion in the body.  Being surrounded by an extensive capillary network, 
Type I cells take almost 80% of the organ’s volume and they are the primary 
site of chemosensation (Gonzalez et al., 1994). Type I cells, which are 
responsible for catecholamine release, are surrounded by Type I cells. Neural 
signals from the carotid body are relayed to the NTS via the carotid sinus 
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nerve (Campanucci & Nurse, 2007; Gonzalez et al., 1994; Kumar & Bin-
Jaliah, 2007). 
 
1.7.2: Main reflexes mediated by the carotid body; hypoxia and hypercapnia 
Reductions in PAO2 or hypoxia constitute the most well known stimulus of the 
carotid body, which increases its afferent discharge exponentially over the 
range of 100 to 30 mmHg (Biscoe et al., 1970; Kumar & Bin-Jaliah, 2007; 
Marshall, 1994). The chemotransduction process involved has yet to be 
clarified despite extensive research. In fact several theories have been 
proposed with purines (Lahiri et al., 2007), catecholamines (Gonzalez et al., 
1994) and cholines being putative neuromodulators in the process (Nurse, 
2005). 
Rises in PACO2 above a threshold and acidosis (respiratory or metabolic) 
cause linear increases in the firing discharge of the carotid body that plateau 
at 100mmHg PACO2 (Lorinc et al., 1991; Lahiri & Forster, 2003). The carotid 
body response has been widely thought to be mediated by changes in the 
intracellular pH status of type I cells. It has been shown that the time constant 
of the ventilatory increases due to carotid body stimulation by CO2 is between 
8 and 26 seconds accounting for up to 50% of the total ventilatory response to 
hypercapnia (Bruce & Cherniack, 1987; Dahan et al., 1990; Tansley et al., 
1998; Weil & Swanson, 1991). Interestingly in the physiological range of 
PACO2, at sea level, chemosensory oscillations are matched by respiratory 
oscillations. This phenomenon, which was firstly observed by Band et al., 
(1976) can be explained by the PACO2 increase and PAO2 decrease at 
expiration and the opposite gas fluctuations at inspiration. Ultimately, the 
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carotid body provides approximately 20 to 30% of the resting ventilatory drive 
(Dejours 1962; Mahamed et al., 2001).  
 
 
1.8: REGULATION OF VENTILATION DURING EXERCISE 
Muscular exercise presents a unique, multifaced and potent stress on the 
ventilatory control system, which has to accommodate the increased need for 
oxygen and disposal of carbon dioxide by the active musculature while 
maintaining optimal blood acidity and gases status. Exercise hyperpnoea or 
the increases in breathing seen during exercise, represents the largest 
ventilatory adjustment during a normal human life that is inherent even in 
walking which is the most ordinary of human activities. Despite the immense 
physiological importance of this phenomenon, and the great attention that it 
has received by researchers for over a century, the underlying mechanisms 
are not completely understood (Dempsey et al., 1995; Mitchell & Babb, 2006).   
 
 
Respiratory response to exercise 
 
Dynamic exercise 
 
Constant-load exercise 
In the healthy individual, the ventilatory response to dynamic (involving 
rhythmic repetitive movements of muscle groups) exercise performed at an 
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invariable intensity is schematically represented by Figure 1.4. The response 
is characterised by three distinct phases.  
 
 
Figure 1.7: The characteristic three phases of the ventilatory response to 
dynamic exercise. 
 
 
Phase 1 (Φ1) takes place immediately at the start of exercise and is 
characterised by an abrupt rise in ventilation along with an accompanying 
elevation in the pulmonary gas exchange rates for oxygen and carbon dioxide. 
Increases in oxygen consumption and carbon dioxide production also occur 
and they could match closely the gas exchange rates. A mismatch between 
production and exchange could also occur due to metabolically-produced CO2 
being taken-up by the muscle and venous blood, and result in a transient 
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plateau of ventilation for up to 20 seconds (Mateika & Duffin, 1995; Ward, 
2000; Whipp, 1991; Whipp & Ward, 1991). 
Subsequently, phase 2 (Φ2) is characterised by an exponential increase in 
ventilation, oxygen uptake and carbon dioxide elimination. The time constant 
of the exponential increases of oxygen uptake is smaller that that for 
ventilation and carbon dioxide elimination, which are almost similar (~10% 
difference). The shorter O2 time constant has been thought to depict 
reasonably faithfully the time course of oxygen uptake by the exercising 
muscle since body stores for O2 are limited. In contrast the CO2 capacity of 
body stores is large and accounts for the slow kinetics of carbon dioxide 
output that has been suggested to ‘dictate’ those of VE. As a result of the 
dissociation between oxygen, carbon dioxide and ventilation kinetics, the 
partial pressure of oxygen in arterial blood tends to decrease whereas that of 
the carbon dioxide slightly increases (Mateika & Duffin, 1995; Whipp, 1991; 
Whipp 2000). 
The last portion of the ventilatory response to dynamic exercise of constant, 
moderate intensity is characterised by a steady-state level of respiration. At 
his stage there is a match between pulmonary gas exchange and metabolic 
rate that results in near-resting PACO2 and PAO2. During exercise of constant 
yet heavy intensity Φ3 is characterised by continuous elevations in respiration 
so that clearance of carbon dioxide is increased at a higher rate than 
metabolic rate, resulting in reductions in PACO2. These changes usually occur 
along with lactic/metabolic acidosis (Mateika & Duffin, 1995; Ward et al., 
2000; Whipp, 1991; Whipp & Ward 1998).       
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Incremental exercise 
During the initial stages of exercise incremental intensity with minute 
increments, respiration increases proportionally with oxygen uptake and/or 
carbon dioxide clearance, resulting in near-resting PACO2 and blood acidity. 
Upon reaching 40-60% (depending on fitness) of the maximum aerobic 
capacity, ventilation increases disproportionally to oxygen uptake and carbon 
dioxide clearance. This point of inflation, which has been known as the 
anaerobic threshold, is usually accompanied by elevations in arterial lactic 
acid and decrements in PACO2. As exercise intensity increases to 70-90% of 
the maximum aerobic capacity, the disproportional increases of ventilation to 
oxygen uptake and carbon dioxide clearance become greater. In parallel 
greater elevations and depressions in arterial lactic acid and PACO2, 
respectively, are seen. This other inflation point has been termed as the 
second anaerobic threshold (Mateika & Duffin, 1995; Ward, 1983; 2000). 
     
Isometric exercise 
Performance of isometric (static muscular contraction) exercise is also 
associated with increases in ventilation whose magnitude varies according to 
the level of tension exerted, the duration of effort and the rates of muscular 
fatigue/pain induced (Duncan et al., 1981; Muza et al., 1983). As such, static 
muscle contractions exercise below  15% of the maximum voluntary 
contraction (MVC), which are generally regarded as non-fatiguing, induce 
small increments (<2 L/min) in breathing that are maintained until the 
contraction is ceased. Greater increases in ventilation (>5 L/min) are seen 
after approximately 3 minutes of static exercise performed at intensity above 
 38
20% of the MVC or after the onset of muscle fatigue (Fontana et al., 1993; 
Iellamo et al., 1999; Muza et al., 1983). The magnitude of increases in 
ventilation has been also related to the muscle mass involved in exercise 
(Imms & Mehta, 1989; Muza et al., 1983). It has been known that breathing 
rises due to isometric work are inappropriately high for the increases achieved 
in carbon dioxide clearance and oxygen uptake, leading to decreases in 
PETCO2 in PACO2 that are pronounced during the latter stages of relatively 
high-tension exercise (Imms & Mehta, 1989; Poole et al., 1988; Wiley & Lind, 
1971).                                  
 
 
1.9: MECHANISMS CONTROLLING BREATHING DURING EXERCISE 
Uncovering the mechanisms responsible for the increments in respiration in 
response to exercise has been thought as one of the remaining challenges in 
the quest to understand the control of human systemic function (Whipp & 
Ward, 1998). This challenge has long attracted a vast deal of research 
attention yielding various mechanisms, each of which being accountable for 
the phenomenon when given in isolation (Dempsey et al., 1995). These 
mechanisms could be classified to three main categories; a) the non-sensory 
feed-forward mechanism or central command, b) a non-sensory mechanism 
intrinsic to brainstem neurons that acts to potentiate the neural respiratory 
response to stimuli and c) sensory feedback mechanisms (Eldridge, 1994). 
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1.9.1: Central command 
The notion that the drive to increase ventilation during exercise, particularly at 
its onset, originates from various structures in the brain has been long held 
and it was coupled to the observations that respiration increases abruptly 
before any locomotor changes take place. Early evidence for the functional 
importance of these brain areas has been accumulated from employing 
several techniques in animal preparations that comprise selective electrical 
stimulation, localised pharmacological stimulation, focal lesioning and 
antidromic techniques  Regions that have been identified to project into the 
cardiorespiratory integrative areas of the medulla as well as into the locomotor 
‘pattern generator’ in the spinal cord include the cerebral motor cortex, the 
hypothalamus, the mesencephalon and the amygdala (Eldridge et al., 1991; 
Waldrop et al., 1996; Whipp & Ward, 1998). More recently a great deal of well 
designed studies has been conducted on animal preparations (Ordway et al., 
1989), paraplegic and especially non-paraplegic humans with the use of 
partial neuromuscular blockade (Adams et al., 1984; Brown et al., 1990), 
servo-assisted positive pressure ventilation (Poon et al., 1987), imaginary 
exercise (Wuyam et al., 1995), yielding a more comprehensive picture of the 
central command involvement in exercise hyperpnoea. Therefore it has been 
accepted that the mediation of hyperpnoea seen during isometric exercise is 
at least partially accounted for by central command (Asmussen et al., 1965; 
Duncan et al., 1981; Muza et al., 1983; Poole et al., 1988; Victor et al., 1989; 
Wiley & Lind, 1971). Furthermore, it has been widely, but not universally, 
suggested that although central neurogenesis contributes to the rapid 
increases seen at the onset of dynamic exercise (Φ1), it is not essential for 
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mediating the response. Furthermore the contribution of central command in 
the other phases of exercise hyperpnea remains a possibility although 
unambiguous experimental confirmation has yet to be achieved (Mateika & 
Duffin, 1995; Ward et al., 2000; Whipp, 1991; Whipp & Ward 1998). 
 
Non-sensory mechanisms intrinsic to brainstem neurons 
Maintenance and development of the initial increases in ventilation seen at Φ2 
could be also facilitated by a central neurogenic mechanism, which has slow 
dynamics and is known as neuronal short-term potentiation (STP). 
Experiments on animal preparations have shown that when a single 
respiratory stimulus is given, activation of STP aids in the facilitation of a 
smooth exponential increase of breathing. It should be noted though that the 
importance of STP in humans’ respiratory control is not well understood and, 
in addition the mechanism has yet to be anatomically localised (Eldridge, 
1994; Mateika & Duffin, 1995; Whipp & Ward, 1998). 
Another possible, yet ubiquitous, neuronal influence to respiratory control 
attests to the plasticity of the exercise responses based on previous 
experience. This phenomenon, which is known as long-term potentiation of 
exercise hyperpnea, is possibly mediated through serotoninergic pathways, 
and has been primarily evidenced in animals (Whipp & Ward, 1998). 
Therefore a persistent and consistent hyperventilation has been observed in 
goats during the performance of a standard treadmill task after a two-day 
training period in which they completed the same task repeatedly while 
breathing through an imposed external dead space (Martin et al., 1993). 
Similar findings were also reported on human studies (Turner et al., 1997). 
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1.9.2: Sensory feedback mechanisms 
Various feedback mechanisms have been postulated to modulate the 
increases in ventilation during exercise, and they have been classified into two 
main categories; a) respiratory feedback through chemoreceptors and afferent 
input from receptors in respiratory muscles, airways and lungs and b) non-
respiratory feedback from receptors in the heart, vessels, lungs and exercising 
muscle (Eldridge, 1994). 
 
 
1.9.2.1: Respiratory feedback 
 
Central chemoreception 
Changes in blood gases and acidity have been long suggested as a potential 
stimulus for mediating exercise hyperpnoea although exercise up to a 
moderate intensity is not associated with significant alterations in these 
parameters. Therefore, it has been thought that central chemoreceptors are 
unlikely to play an important role given their location, slow response kinetics, 
and that PCO2 of both the arterial and venous blood and in the 
cerebrovascular fluid remain near normal or decrease during light and 
moderate exercise (Bellville et al., 1979; Dempsey et al., 1995; Gardner et al., 
1980; Weil & Swanson, 1991). Further support to that notion has been 
provided by data advocating a failure to alter exercise hyperpnoea after 
manipulation of the acidity of the cerebrovascular fluid (Smith et al., 1988). 
The dampened oscillations in brain extracellular pH that occur secondary to 
these in blood could provide a stimulus to central chemoreceptors. However, 
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the increases in breathing frequency seen during exercise could decrease pH 
oscillations in blood (Murphy et al., 1987), thus precluding a substantial 
contribution of extracellular fluid pH oscillations in the dynamics of ventilation 
during exercise (Dempsey et al., 1995). 
 
Peripheral chemoreception 
On the contrary, the peripheral chemoreceptors are known to be responsive to 
the pH and PCO2 oscillations in arterial blood that occur throughout the 
respiratory cycle (Band et al., 1969; 1980; Cross et al., 1979 a; b; Hornbein et 
al., 1961). Coupled to that, it was hypothesised that ventilation during exercise 
could be related to the changes of slope in either the upstroke or the 
downstroke of the PACO2, which is dependent on the mixed venous 
pulmonary CO2 flux and thus is determined by cardiac output and carbon 
dioxide production (Band et al.,1980; Cross et al., 1982). It has been also 
proposed that the rate sensitivity of the peripheral chemoreceptors to these 
changes in oscillations could account for the precise matching of ventilation 
and carbon dioxide production at rest and during exercise (Mateika & Duffin, 
1995; Saunders 1980). These hypotheses have been challenged on both 
theoretical and experimental basis (Nye, 1994).  
Nonetheless, other studies provided further insight on the potential role of 
peripheral chemoreception. As such, Phillipson and co-workers (1981) 
showed a linear relationship between ventilation and CO2 production under 
isocapnic conditions when CO2 was added or removed from the peripheral 
venous blood of awake sheep with intact carotid bodies. Importantly, that 
relationship became hypercapnic when the carotid bodies were either 
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denervated or blunted by administrating a hyperoxic inspirate (Phillipson et al., 
1981). In conjunction to this, data by Bin Jaliah and associates (2005) in rats 
strongly suggested that the hypermetabolism-hyperpnoea could be due 
mediated via an increase in the sensitivity of the carotid body to CO2. This 
finding implied a potential link between exercise-induced increases in 
metabolism and ventilation, and provided the basis on which the effects of 
metabolism on chemosensitivity were studied as part of this thesis (Chapter 
4). Further evidence supporting the role of peripheral chemoreception in the 
regulation of breathing during exercise has been provided by studies in which 
blunting of carotid body activation by hyperoxia and sodium bicarbonate 
resulted in transient decreases in ventilation during exercise  along with 
slowed ventilatory kinetics, which imply impaired coupling between ventilation 
and carbon dioxide. Coupled to that, an accentuation of ventilatory kinetics 
during exercise has been noted with enhanced carotid chemosensitivity 
through metabolic acidosis or hypoxia (Ward et al., 1987; Whipp, 1994; Whipp 
& Ward, 1998). Additionally the respiratory response to acute metabolic 
acideamia during exercise appears to be mediated through the carotid bodies 
(Whipp & Wasserman, 1980).  
On the whole, animal and human data have collectively suggested that 
peripheral chemosensitivity plays an important role in modulating the tightness 
with which PACO2 is regulated during Φ2 (Whipp, 1994a), contributes ~20% to 
the ventilatory drive of Φ3 (Whipp, 1994b; Whipp & Ward, 1998), and in 
addition it is involved in the hyperpnoea of isometric exercise (Poole et al., 
1988). Importantly it has been also established that the carotid body is 
stimulated by limbs’ movement (Biscoe & Purves, 1967) and a variety of 
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exercise-induced alterations, including increases in K+ (Paterson, 1992), 
adenosine (Lahiri et al., 2007), angiotensin (Allen, 1998), osmolarity (Kumar & 
Bin-Jaliah, 2007), sympathetic activation (Llados & Zapata, 1978; Maskell et 
al., 2006) and temperature (Landauer et al., 1995). 
 
Other respiratory feedback  
It has been purported that afferent feedback from receptors in airways and 
respiratory muscles may also play a modulatory role in breathing during 
exercise. These receptors were suggested to sense the degree of mechanical 
stress and provide input to higher respiratory centres, which modify ventilation 
so as to achieve the maximal possible efficiency. Although these inputs can 
influence ventilation, they can not be considered as a primary drive of 
exercise hyperpnoea (Dempsey et al., 1995; Eldridge, 1994; Poon, 1987).  
 
1.9.2.2: Non-respiratory feedback 
Feedback not directly related to breathing or blood gases can also exert an 
influence to the mediation of increases of breathing during exercise. 
Therefore, type III and IV receptors in the muscle sensitive to mechanical 
(mechanoreceptors) and metabolic (metaboreceptors) changes (detailed 
information on the physiological importence of these receptors is given in the 
next part of the introduction section), respectively, have been suggested to 
provide a respiratory drive during dynamic exercise by many (Clark et al., 
1995; Grieve et al., 1999; Oelberg et al., 1998; Piepoli et al., 1995; 1996; 
1999; Scott et al., 2003), but not all (Francis et al., 1999) investigators. 
Likewise the question whether this drive is obligatory in exercise hyperpnoea 
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has been debated in the scientific community. Recently, the working group of 
Haouzi as well as others have strongly supported that intramuscular receptors 
sensitive to vascular distention / pressure could operate along with the 
mechano- and metaboreceptors in regulating ventilation and arterial gases 
during exercise (Haouzi et al., 1993; 1999; 2001; 2003; 2005; 2006; 
Williamson et al., 1993).   
Activation of receptors in the heart and lungs has been also purported to 
contribute to respiration increases during exercise, according to the long held 
theory of ‘cardiodynamic hyperpnoea’. This theory has arisen by the 
observation of the respiratory exchange ratio remains close to resting values 
during the initial 15 seconds of exercise, suggesting proportional increases in 
alveolar ventilation and cardiac output or pulmonary blood flow (Mateika & 
Duffin, 1995). In favour of this hypothesis have been studies showing reflex 
hyperpnoea in response to local mechanical distension of the heart and 
adjacent vasculature (Jones et al., 1982; Kostreva et al., 1975). However data 
on heart transplantation patients were not consistent with the ‘cardiodynamic’ 
theory as an essentially normal hyperpnoeic response to exercise was 
demonstrated (Banner et al., 1988). Moreover, ventilation was found not to 
respond rapidly to an abrupt increase in resting heart rate induced by 
pacemakers (Jones et al., 1981). It has been recently concluded that the 
parallel increases in ventilation and cardiac output seen at the start of 
exercise appear to be elicited by a common central mechanism in the medulla 
and therefore the operation of a cardiac mechanism in mediating exercise 
hyperpnoea does not seem to be obligatory in health (Mateika & Duffin, 1995). 
In contrast, cardiac and particularly pulmonary haemodynamics could be 
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implicated in the abnormally increases in ventilation seen during exercise in 
CHF (Guazzi et al., 2007).  
 
1.10: REGULATION OF VENTILATION DURING EXERCISE IN CHF 
The excessive respiratory response to exercise seen in patients with 
moderate to severe chronic heart failure has been strongly related to 
symptoms of breathlessness and their limited exercise capacity (Clark et al., 
1996; Coats, 2001; Piepoli et al., 2008; Witte & Clark, 2007). Various factors 
were proposed by earlier studies to underpin exercise hyperventilation in this 
condition including increased dead space, PVP, PVR and impaired right 
ventricular function. More recent investigations have strongly supported that 
an increased drive to breathe due to hyperactive central and peripheral 
chemoreceptors (Chua et al., 1996; Ponikowski et al., 1997) as well as muscle 
metaboreceptors (Piepoli et al., 1996; 1999; Scott et al., 2003) may play an 
important role in the abnormal exercise responses of CHF.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 47
PART 3: MUSCLE AFFERENTS 
 
 
1.11: BASIC ANATOMY AND PHYSIOLOGY 
 
It is well known that the regulation of the cardiovascular responses to exercise 
is mediated by the action of and interaction between central and peripheral 
mechanisms. Therefore neural signals from higher centres of the brain 
(central command), arterial and carotid baroreceptors and small afferents 
located in the active skeletal muscles converge in the cardiovascular 
integrative centres of the brainstem (i.e. ventrolateral medulla, NTS), whose 
neural projections to vessels, heart and adrenal medulla control heart rate, 
blood pressure, stroke volume and peripheral resistance by adjusting 
parasympathetic and sympathetic activation (Figure 1.5) (O’Leary, 2005; 
Sinoway & Li, 2005; Smith et al., 2005).  
 
 
 
Figure 1.8: Neural control of circulation during exercise (Adapted from Smith 
et al., 2005) 
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Muscle afferents are sensory nerve fibres that have free endings located in 
close proximity to blood vessels, tendon and collagenous tissue in the muscle 
interstitial space. Two types of polymodal neural fibers have been identified to 
provide neural signals to the NTS through the dorsal horn of the spinal cord 
regarding the metabolic, pressure and mechanical changes taking place 
during muscular work; type III myelinated fibers that are predominantly 
responsive to mechanical deformation and pressure changes (i.e. 
mechanoreceptors) and type IV non-myelinated fibres that are mostly 
sensitive to metabolic changes (i.e. metaboreceptors) (Kaufman & Rybicki, 
1987; McCloskey & Mitchell, 1972). Activation of mechanically- and 
metabolically sensitive receptors induces distinct cardiovascular responses 
that are encompassed by the terms mechanoreflex and metaboreflex (or 
ergoreflex), respectively. Collectively, the responses that arise from the 
activation of the mechano- and metaboreflex are known as the exercise 
pressor reflex (Rowell & O’Leary, 1990; Smith et al., 2005). 
 
1.12: MECHANORECEPTORS 
Activation of receptors sensitive to mechanical deformation by rhythmic / 
sustained passive stretch or external muscle compression in awake humans 
and anaesthetised animals has been consistently shown to decrease 
parasympathetic activation and increase heart rate (Fisher et al., 2005; 
Gladwell et al., 2002; 2005; Matsukawa & Nakamoto, 2008; Stebbins et al., 
1988; Tokizawa et al., 2004 McClain et al., 1994; Williamson et al., 1994). 
Activation of mechanoreceptors has been also found to increase muscle or 
cardiac nerve sympathetic activity (Cui et al., 2006; 2008; Murata & 
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Matsukawa, 2001) and/or blood pressure in some studies (Bell & White, 2005; 
Drew et al., 2008; Fisher et al., 2005), but not all (Gladwell et al., 2002; 2005). 
Whereas the above discrepancies have been attributed to methodological 
differences amongst studies, it has been widely suggested that the tonically 
active feedback provided by mechanoreceptors to the cardiovascular 
integrative centres contributes to the heart rate and blood pressure increases 
as well to the sympathoexcitation seen during dynamic exercise. Elevations in 
sympathetic outflow during exercise in turn are well known to serve two main 
important functions. First is redistributing the available cardiac output towards 
the active skeletal muscle by inducing vaso- and venoconstriction of vascular 
beds that are not involved in exercise. Second, is to ensure adequate 
perfusion of the heart and brain in face of the large rises in muscle blood flow 
(O’Leary, 2006; Sinoway & Li, 2005). In support to the purported role of 
mechanoreceptors on the above cardiovascular adjustments, evidence 
suggesting mechanoreceptor-mediated increases in cerebral blood flow 
(Jorgensen et al., 1992) and vasoconstriction of the renal vascular bed 
(Middlekauff et al., 1997; Momen et al., 2003; Sinoway & Li 2005; Victor et al., 
1989) has been presented. Interestingly enhanced cardiovascular responses 
to mechanoreceptor activation in presence of sustained metaboreceptor 
activation were observed in some data (Bell & White, 2005), but not in the 
available majority thereof (McClain et al., 1994; Fisher et al., 2005; Leshower 
et al., 2001). Again, while the disparity in the findings could be due to the 
different methodological approaches employed, it is well known that a high 
percentage of type III mechanically sensitive afferents are also activated by 
chemical stimuli (Kaufman & Rybicki, 1987; Rotto & Kaufman, 1988). 
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1.13: METABORECEPTORS 
 
Activation of muscle receptors sensitive to chemical changes has been known 
to be largely responsible for the blood pressure and sympathetic nervous 
system activity increases seen during isometric exercise and may also 
contribute to the aforementioned changes during severe dynamic exercise 
(Kaufman & Rybicki, 1987; Rowell & O’Leary, 1990). Supporting evidence for 
this has been provided by experiments in which entrapment of contraction-
related metabolites in the active muscle was ensured by occluding the 
circulation to the limb by either inflation of a cuff around the exercising limb 
(human experiments; post exercise circulatory occlusion-PECO) or by 
hindlimb aortic constriction (animal experiments). This ensures that nerve 
endings from type IV afferents remain sensitised by contraction related 
metabolic products such as H+, lactic acid, bradykinin, K+, arachidonic acid, 
adenosine, analogues of ATP, diprotonated phosphate and prostaglandins 
(Kaufman & Forster, 1996). Therefore, entrapment of contraction-related 
metabolites has been shown to maintain the increases in systemic blood 
pressure and in sympathetic nervous system activity at various vascular beds, 
including that of the kidneys, skin and inactive muscle, seen during isometric 
exercise (Momen et al., 2003; Ray et al., 1994; Wallin et al., 1989). In 
addition, data on animals and humans has suggested that activation of 
muscle metaboreceptors is involved in the regulation of central 
haemodynamics and ventricular performance during exercise in healthy 
animals and humans and in CHF (Crisafulli et al., 2003; 2008; O’Leary & 
Augustyniak, 1998; Sheriff et al., 1998; Shoemaker et al., 2007).  
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1.14: MUSCLE REFLEXES IN DISEASE 
Given the importance of the metaboreflex and mechanoreflex in 
cardiovascular regulation during exercise in health, extensive research has 
been conducted to examine whether these regulatory mechanisms contribute 
to the impaired exercise tolerance and cardiovascular and respiratory 
regulation seen in the sympathoexcitatory condition of CHF. Therefore, a 
number of studies have collectively showed that the contribution of the muscle 
metaboreflex to the blood pressure, leg vascular resistance and blood flow, 
and ventilatory responses to dynamic handgrip exercise were significantly 
higher in CHF patients than in normals (Grieve et al., 1999; Hammond et al., 
2000; Notarius et al., 2001; Piepoli et al., 1996; 2006; Scott et al., 2002a; b; 
2003).  Furthermore, Piepoli and co-workers (1996) found that 6 weeks of 
forearm physical training reduced the metaboreflex contributions to the 
aforementioned physiological variables, thereby improving the exercise 
responses of CHF patients. Moreover, the degree of metaboreflex contribution 
to ventilation was strongly associated with a worse clinical status, lower 
exercise tolerance, pronounced exercise hyperventilation, baroreflex 
impairment and sympathetic activation in CHF patients (Ponikowski et al., 
2001; Piepoli et al., 2006).  
In contrast, other data obtained on humans and animal models have 
suggested that the muscle metaboreflex is down-regulated in CHF (Sterns et 
al., 1991) and that the overactivity of muscle mechanoreceptors plays the 
pivotal role in the mediation of the abnormal cardiovascular responses to 
exercise (Middlekauff et al., 2004; Negrao et al., 2001; Smith et al., 2005;). In 
addition investigations in which changes in renal blood flow during were 
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estimated with positron emission tomography (Momen et al., 2003) and 
ultrasound imaging (Middlekauff et al., 2000) provided evidence for 
mechanoreceptor-mediated renal vasoconstriction during isometric exercise in 
CHF.  
Notably, White and associates have reported decreased systemic arterial 
pressure values during voluntary and electrically evoked isometric 
contractions and subsequent circulatory occlusion in CHF patients as 
compared to their age-matched healthy counterparts. Consequently they 
argued for a decreased neural input from both the metabo- and 
mechanoreceptors to the exercise pressor response in this condition 
(Carrington et al., 2000; Sinoway & Li, 2005).   
Despite the lack of consensus amongst studies, that could be related to the 
differences in the exercise protocol (i.e. modality, duration and intensity) and 
muscle group used and the severity of heart failure in the patients’ cohort 
(Carrington et al., 2004), it has been accepted that the abnormal 
cardiovascular and ventilatory responses to exercise in CHF are partially 
accounted for by increased activation of both the metabo- and the 
mechanoreflex (Piepoli et al., 2008; Witte & Clark, 2007).   
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PART 4. AIMS AND OBJECTIVES OF THIS PHD; PROPOSED 
STUDIES 
 
The experimental studies included in the present PhD thesis sought to 
investigate the following subjects; 
• Given the role that muscle reflex systems appear to play in 
cardiovascular regulation during exercise, we aimed to examine 
whether the muscle metaboreflex is also involved in the regulation of 
pulmonary blood flow during exercise (Chapter 3). The sustained 
activation of the muscle metaboreflex in the post-exercise period by 
circulatory occusion enabled us to assess the effect of metaboreflex-
mediated sympathoexcitation on Doppler-derived estimates of 
pulmonary artery pressure without the confounding influence of 
exercise-related increases in cardiac output. Coupled to that, we 
investigated in a separate study (Chapter 6) the pulmonary 
haemodynamic response to the combined activation of the muscle 
metaboreflex and muscle mechanoreflex induced in the post exercise 
period by circulatory occlusion and passive muscle stretch, 
respectively.  
• In light of the commonly held postulation that the muscle metaboreflex 
interacts with the ventilatory chemoreflex in the mediation of abnormal 
breathing during exercise in CHF (Coats, 2001; Schmidt et al., 2005; 
Tumminelo et al., 2007), we aimed to examine whether the combined 
activation of these reflexes affects ventilation in healthy subjects 
(Chapter 5). Activation of the metaboreflex and chemoreflex were 
 54
accomplished by post-exercise circulatory occlusion and hypercapnia, 
respectively.  
• Recent animal data evidenced an increase in the ventrilatory sensitivity 
to CO2 after metabolic rate was elevated by insulin infusion, and thus 
suggested that this phenomenon might be implicated in the mediation 
of exercise hyperpnoea (Bin Jaliah et al., 2005). We aimed to assess 
whether small elevations in metabolic induced by food ingestion would 
affect the ventilatory sensitivity to inhaled carbon dioxide in healthy 
humans (Chapter 4). 
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CHAPTER 2: 
METHODS 
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2.1: END-TIDAL GAS FORCING  
Two investigations reported in this thesis required manipulation of the gases 
that were breathed by subjects in order to induce normoxic hypercapnia. In 
other words, the inspired gases were controlled in such a way that the partial 
pressure of oxygen in arterial blood was maintained in normal levels 
(normoxia or euoxia) whereas the partial pressure of carbon dioxide in arterial 
blood was increased (hypercapnia).  
 
Basic Principles 
The technique used in order to manipulate the inspired gases is called 
dynamic end-tidal gas forcing (DEGF). The first comprehensive attempt of 
DEGF took place in 70’s by Swanson’s group (Swanson & Bellville, 1975). 
The technique was further developed in the Laboratory of Physiology in 
Oxford University by Robbins and co-workers (Robbins et al., 1982a; 1982b). 
One fundamental principle underlying this DEGF is that partial pressures of 
oxygen and carbon dioxide in the alveolar air of healthy individuals are almost 
identical to these in the arterial blood that leaves the lungs. Thus the latter can 
be indirectly assessed by sampling the concentration of oxygen and carbon 
dioxide in expired gas at the end of expiration. DEGF involves manipulation of 
the inspired air so as to attain the required end-tidal partial pressure of a gas. 
The appropriate inspired values of gases required to induce certain end-tidal 
values at given ventilation are predicted by a cardio-respiratory mathematical 
model. This model, which relates changes in end-tidal gases to change in 
ventilation, firstly utilises the mass balance equations for oxygen and carbon 
dioxide in the lung. For instance the amount of a gas that enters the lungs via 
 
 57
inspiration should be equal to the amount leaving the lungs plus the rate of 
change of this gas in the alveoli. 
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where V?A is alveolar ventilation, PA is the partial pressure of the gas in 
question in the alveoli, PI is the partial pressure of inspired gas, V?
 
L is the lung 
volume, λ is a coefficient dependent on units, Q˙  B is pulmonary blood flow, CA 
is the arterial concentration of the gas in the blood, and CV is mixed venous 
concentration of the gas in the blood. 
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A two-compartment model of the respiratory system that incorporate a central 
and a peripheral component, as well as a multi-compartment model of the 
circulation are used to solve the above equation (Robbins et al., 1982a; 
1982b). 
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Correction 
The correction factor of the scheme compares the actual end-tidal values with 
the desired ones and adjusts the predicted values of inspired gases in order 
to minimise the error. The adjustment in the inspired gas partial pressure (Pi) 
is calculated according to the following equation for a given breath n: 
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where PIC is the predicted inspired partial pressure, PETd is the desired end-
tidal partial pressure, PETm is the measured end-tidal partial pressure, gp is the 
proportional feedback gain, and gi is the integral feedback gain. The gains can 
be adjusted manually, and the value of gp is set to be ten times that of gi. The 
proportional gain serves to reduce the effects of breath-to breath-variation, 
and the integral gain serves to eliminate drift and steady-state error (Robbins 
et al., 1982a; 1982b). 
 
 
Apparatus for DEGF 
 
A photographic display of the main parts that comprised the apparatus used 
for DEGF is shown in Figure 2.2. The subjects were breathing through a 
mouthpiece that was used along with a nose clip to ensure exclusive mouth 
breathing. The mouthpiece assembly (Figure 2.1), which integrated a saliva 
trap, had a port for a gas-sampling tube and was connected to a volume-
measuring turbine and to a pneumotach.  
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The gas-sampling tube was connected to a four-channel mass spectrometer 
(AirSpec 2000, Case Scientific, London, UK) that sampled expired air at a rate 
of 80 mL/min and that was tuned to detect O2, CO2 and N2 on the basis of 
their mass-to-charge ratio. Output data from the mass spectrometer was 
updated every 20 ms. Volumes and flows of gases were measured with a 
combination of a turbine (Cardiokinetics Ltd., UK) and a pneumotach 
(Pneumo Hans Rudolph pneumotach amplifier 1, Shawnee, USA). The 
turbine used was a transparent plastic tube which houses an impeller that 
rotates as air moves past it. The turbine assembly was surrounded by a 
photodetector pickup device (Durant VMM-400) that collects information on 
the speed and direction of rotation of the impeller, which is then converted to 
inspiratory and expiratory volumes (1 revolution = 2 mL). Given that the 
turbine is not affected by water vapour it is ideal for volume measurements. 
However, a substantial delay is present due to the inertia of the impeller 
caused by the change of phase as inspiration progresses expiration and vice 
versa. Detection of phase change is done by the pneumotach device, which 
consists of a cylinder (27 mm long by 27 mm diameter) containing a 
honeycomb of fine tubes. The honeycomb provides a small resistance to flow 
(approximately 3 mmH2O/s/L) resulting in a small pressure drop across the 
device. An accurate measurement of flow is made since flow through the 
honeycomb is laminar up to 130 L/min. The information from the mass 
spectrometer, turbine, and pneumotach was collected by a computer. 
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Figure 2.1: Schematic representation of the mouthpiece 
apparatus used for EDGF.A; saliva trap, B; turbine, C; 
photodetector device. 
 
 
 
End-tidal profiles were generated using a computerized dynamic end-tidal 
forcing system program (BreatheM, University of Oxford, UK), in which the 
actual end-tidal gas composition was recorded every breath and compared 
with desired values by a computer. The computer then passes a signal to a 
pair of control boxes (MKS Instruments PR 4000 F, Germany), each 
controlling two of four gas channels: compressed air, O2, CO2, and N2. The 
control boxes are designed for use with mass flow controllers (MKS 
Instruments 1559A, Germany), which accurately measure and control the 
mass flow rate of gases through the opening of valves for O2, CO2 and N2 that 
allow a calculated duration of flow of each gas at a known rate. Because 
mass flow is measured, correction for temperature and pressure variations is 
not necessary. Before the gas mixture reaches the subject it is passed 
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through a set of humidifiers (Fisher & Payhel Healthcare HC150, Auckland, 
New Zealand) to make it easier to breathe.  
 
Safety 
The safety of the subjects while using the fast gas mixing system and the 
chamber was assured by monitoring their O2 saturation in arterial blood and 
by monitoring the inspired levels of O2 and CO2. Saturation was measured by 
a pulse oximeter (Datex-Ohmeda 3900, General Electrics). Audiovisual 
alarms were triggered when preset safety levels were exceeded. Heart rate 
was also continuously monitored and subjects were instructed to immediately 
inform the experimenter in case of any signs discomfort (i.e. light-headedness 
and dizziness) that could arise with hypercapnia. A 2-3 second surge of light-
headedness was reported by a number of participants during the transition 
from normal air breathing to normoxic hypercapnia.  
 
 
Calibration 
Prior to each experiment calibration of the mass spectrometer and of the 
DEGF system was taken place. For the calibration of the former, gases of 
known O2 and CO2 concentration (15% and 5% respectively) as well as 100% 
Helium were used. Gases of known O2 and CO2 concentrations were also 
used for calibration of the DEGF whereas volumes were calibrated through 
repeated evacuations of a 1L pump. 
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Brief description of running the DEGF 
A standard procedure was followed prior to each experiment that utilised 
DEGF. Therefore subjects were initially asked to sit quietly on a chair and 
breathe through a mouthpiece that was used with a noseclip. Subjects rested 
for at least 15 minutes while watching television in order to become unaware 
of their breathing. During the final 5 minutes of that period basal values of 
PETCO2 and PETO2 were determined. These values were used to construct the 
function according to which increases in PETCO2 (hypercapnia) in normoxia 
(PETO2 =100 mmHg) would be forced later during the experiment. 
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Figure 2.2: Experimental set up of the laboratory for end-tidal forcing studies. A; computer, B; 
heart rate monitor, C; pulse oximeter, D; control boxes, E; humidifiers, F; mass flow controllers, 
G; mouthpiece apparatus, H; pneumotach and I; mass spectrometer. 
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2.2: ECHOCARDIOGRAPHY 
Echocardiography, which is one of the earliest applications of medicine-related 
ultrasonography, has been extensively used in the clinical setting for diagnostic 
purposes as well as in research owing to its non-invasive nature and its ease of 
use. Echocardiography employs the principles underlying ultrasound imaging so 
as to yield multi-dimensional pictures, examine the morphology of the heart, 
detect blood flow across heart’s valves and measure its velocity. 
 
Ultrasound imaging  
Ultrasound is generated by a physical principle known as the piezoelectric 
effect. If an electric voltage is applied across opposite surfaces of a 
piezoelectric material, the material will physically oscillate producing pressure or 
sound waves that are inaudible to the human ear (ultrasound). The second 
important feature of a piezoelectric material is that it will produce an electrical 
impulse when it is struck by a sound wave. Such a piezoelectric element 
constitutes the primary component of an ultrasonic transducer which also 
incorporates electrodes that electrically excite the element and detect the 
electric impulses.  
The transducer transmits a series of very short pulses (batches) of ultrasound 
which while traveling through the human body, they cross various interfaces. 
This causes some of the sound waves to be reflected back to the transducer, 
whereas the remainder is refracted traveling further into the tissue until the next 
interface. Such interfaces in the heart are usually the junctions formed between 
blood and the heart valves or the myocardium. The amount and/or strength of 
the reflected sound waves (echoes) back to the transducer depend on the 
difference in density of the two materials at the interface, the depth of 
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ultrasound penetration in the tissue and also the angle at which the sound 
waves strike the interface. 
After the reflected waves are received by the transducer, they are amplified, 
and processed by means of determining the distance of the reflector given that 
the wave propagation velocity is known. Ultimately a two-dimensional image of 
the insonated tissue is built up with returning echoes being shown as variations 
in brightness. Once all of the echoes of interest have returned, another batch of 
ultrasound is generated from the transducer. The rate or frequency at which 
batches are sent can be adjusted by the depth control of an ultrasound 
machine. A decrease in frequency will enable collection of information from a 
more distal part at the expense of image quality, and vice versa.  
Imaging of the heart presents two main issues that necessitate the use of 
special transducers; the heart is relatively large structure that is situated behind 
an arrangement of ribs that are impermeable to ultrasound, and b) the 
ultrasound signal has to be directed in between the ribs. Therefore for cardiac 
investigations a special transducer is used that creates a fan of ultrasound 
(usually consisting of 120 lines) thereby producing a wedge-shaped image 
(Figure 2.3). Resolution of images with this configuration is high when the 
insonated tissue lies close to the transducer and vice versa  
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Figure 2.3: Graphic representation of the scan lines emitted by a 
transducer used for cardiac investigations. Note that as distance from 
the transducer increases the spreading of scan lines leads to reduction 
in resolution.  
 
 
The spatial resolution of an image determines how well the structures that lie 
close together are distinguished or identified. Spatial resolution is further divided 
into lateral and axial resolutions which refer to the distinguishing of the 
structures that are situated side-by-side in a horizontal arrangement and at 
slightly different depths in a vertical arrangement, respectively. Lateral 
resolution is affected by the density of scan lines, where as axial resolution 
depends to the wavelength or frequency of the ultrasonic beam. Lateral and 
axial resolution can be optimised by utilising a high frequency transducer at the 
expense of ultrasound penetration (depth). Temporal resolution, which refers to 
the ability to accurately locate structures or events at a particular instant of time, 
is important for studying moving structures such as blood jets. Temporal 
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resolution is dependent on frame rate, which is improved with minimising depth 
as well as the density of the scan lines at the expense of lateral resolution.  
Importantly, when high accuracy measurements are required, they have to be 
performed along a scan line rather than across scan lines, especially if the 
structure to be measured is placed far from the transducer. For instance, if the 
thickness of a cardiac wall is to be determined, the orientation of the wall 
boundaries should be adjusted in such a way so that they fall across to a scan 
line. If the wall’s boundaries were adjusted so that they fell along scan lines, 
then the chance of obtaining an inaccurate measurement would be increased 
as the boundaries could lie between scan lines. This possibility for inaccurate 
measurements is further raised when the distance between the structure of 
interest and the transducer becomes greater (Hatle & Anglesen, 1985). 
 
Doppler Ultrasound 
Doppler ultrasound is the modality used in order to examine the flow of blood 
through organs, vessels and valves. The modality is based on the principle of 
the Doppler effect, which was named after the person who firstly noticed it, 
Christian Johann Doppler. Therefore Doppler, who observed that the colour 
appearance of the stars was different depending on the relative movement 
between the observer and the light source, argued that stars appearing red 
move away from the earth whereas those appearing blue move toward it.     
The Doppler effect also applies to sound waves, given that they share similar 
properties to light waves. There are many everyday examples of the Doppler 
effect; train whistles, police or fire sirens and race car engines produce a sound 
with a higher pitch when they move towards a standing observer than that 
produced when they move away from the observer. A sound of higher pitch, or 
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of higher frequency, is received by the observer due to the denser wave profile 
arising from the fact that the source of the sound is travelling in the same 
direction as the sound waves. As the source of the sound passes and moves 
away from the observer the sound wave profile is not as dense owing to the 
different direction of travelling that the sound waves and the source of the 
sound wave.  
In the setting of measuring blood flow the modality of Doppler ultrasound is 
applied as follows. A sound wave pulse of known frequency is transmitted to the 
blood tissue and it is reflected by the red blood cells back to the transducer. If 
blood was stationary then the frequency of the reflected sound wave will be the 
same with that from the initially emitted sound wave. If the blood was moving, 
the reflected waves will have a different frequency that depends on the direction 
of the flow. The direction of a flow In Doppler ultrasound is signified by a two-
colour spectrum whereas the velocity of the flow by the intensity of the 
spectrum’s colour (Figure 2.4). For instance in figure illustrates an example of 
such a spectrum in which flow towards the transducer (positive frequency shift) 
is denoted by a red colour whereas flow away from the transducer is indicated 
by a blue colour (Hatle & Anglesen, 1985; Houston & Simpson, 1988).  
 
 
 
Figure 2.4: The two-colour spectrum used in Doppler ultrasound to indicate the 
velocity and direction of a flow.  
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The frequency difference between the emitted and returning waves is given by 
the following equation.  
                                                     
C
vff θcos2=Δ  
Where Δf  is the frequency shift, v is the velocity, 8 is the angle between the 
direction of the flow and the sound wave beam (assumed to be 0° degrees 
Celcius) C is 1540 m/s, which is the velocity of sound in tissue and f is the 
frequency of the emitted sound wave. Δf is measured by the ultrasound 
machine, whereas velocity of the blood flow can be calculated from equation 
(Hatle & Anglesen, 1985). 
                                                     θcos2 f
fCv Δ=     
 
Modes of Doppler Imaging 
Pulsed and continuous wave Doppler represent the two different modalities that 
are used to investigate low and high velocity flows, respectively. In pulsed wave 
Doppler (PWD), the emission of a sound wave pulse is followed a pause and 
the next pulse is not sent out until the reflection returns to the transducer. PWD 
is also used in order to examine flow at a specific point in the imaging plane. A 
small time-gate or sample volume is positioned at this point along the path of 
the beam allowing the ultrasound machine to calculate how long it will take for a 
transmitted sound pulse to travel to and to be reflected back from the red blood 
cells in the sample volume and travel back to the transducer. A very important 
technical limitation of PWD that relates to the fact that velocities are being 
sampled by the pulses is that it can not reliably assess velocities that are higher 
than 1m/s (Hatle & Anglesen, 1985; Houston & Simpson, 1988).   
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Continuous wave Doppler (CWD) overcomes this limitation by employing a two-
transducer arrangement in which one transducer continuously emits pulses 
along a focused pathway, and the other continuously receives the 
backscattered pulses. The receiving transducer is positioned so that its focal 
zone intersects that of the emitting transducer over a long distance. This 
instrumentation, which constantly assesses the frequency shifts obtained from 
the region of the intersection, is used for evaluating high velocity flows in the 
heart such as these of mitral and tricuspid regurgitation jets (Houston & 
Simpson, 1988).  
 
Spectral analysis 
The returning signals collected from PWD and CWD are undergone directional 
separation by means of being split up into two components; one of the 
increased frequencies from structures moving away from the transduced 
(positive frequency shift) and one of decreased frequencies from structures 
moving away (negative frequency shifts). The positive and negative shifts are 
plotted on either side of a horizontal zero line, with the distance from the 
baseline denoting the frequency shift that is directly related to the velocity of the 
flow. Time is integrated in the plot along with an ECG signal and a respiratory 
waveform allowing for the association of flow events to a particular point of the 
heart and breathing cycles (Figure 2.5). 
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Figure 2.5: A three-beat velocity profile of a tricuspid regurgitation jet 
measured in CWD. Upper trace: electrocardiogram; middle trace: 
Doppler signal (related to velocity scale); lower trace: index of 
respiratory movement 
 
The relationship that exists between the pressure and velocity of an ideal fluid 
was firstly described by the mathematician Daniel Bernoulli. Bernoulli stated 
that an increase in the speed of the fluid occurs simultaneously with a decrease 
in pressure.   
The ultrasound machine makes use of a modified version of this equation in 
order to calculate the pressure drop across an orifice assuming that the 
following conditions are met: The velocity before the orifice is low, the orifice is 
short in length and the ultrasound beam is well aligned with the flow. 
 
The modified Bernoulli’s equation is 
ΔP = 4v2    
Where ΔP is the pressure drop across the orifice in mmHg, and v is the flow 
velocity (m/s). The equation is used for the calculation of both peak and mean 
pressure drops; the difference being that in the first case only the point furthest 
away from the baseline of the spectral waveform is measured, while a trace of 
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the entire profile of a spectral waveform is needed for the mean pressure drop 
to be calculated (Torbicki & Kurzyna, 2000; Yock & Popp, 1984). 
 
Echocardiographic measurements obtained for the thesis investigations 
Three echocardiographic views were utilised for the purposes of this thesis; 4-
chamber and 5-chamber apical views and a parasternal long axis view (figure 
2.6). The two apical views are obtained from the lateral part of the fourth or fifth 
intercostal space and they are used for the visualisation of the tricuspid valve 
and of the aortic valve. The parasternal long axis view is obtained from the 
second or third intercostal space, just lateral to the sternum, and it is used for 
the visualisation of the aortic valve in a vertical arrangement to accurately 
measure its diameter. 
 
 
 
Figure 2.6: A (apical 4-chamber) and B (5-chamber); Right ventricle (1), 
left ventricle (2), right atrium (3), left atrium (4) and aortic valve (5). C 
(parasternal long-axis view); Aortic valve (1), left ventricle (2), mitral valve 
(3) and left atrium (4). 
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Tricuspid regurgitation and estimation of systolic pulmonary artery pressure 
Estimation of SPAP with Doppler ultrasound was initially applied to patients with 
pathologically elevated tricuspid regurgitation in early 80’s (Yock & Popp, 1984). 
It was later shown that a physiological regurgitation could be detected across 
the tricuspid valve with Doppler in 80% normal people (Mc Quillan et al., 2001). 
This non-pathological finding can provide valuable indirect information about 
changes in pulmonary artery pressure in the absence of invasive techniques. 
The tricuspid regurgitation is a fast flowing jet travelling at velocities of more 
than 2 m/s and it is measured in CWD mode from the apical 4-chamber view. 
To measure the velocity of the regurgitation jet, visualisation of the tricuspid 
valve is done in two-dimensional black and white mode and then the jet is 
identified in colour Doppler mode as it flows from the right ventricle into the right 
atrium during systole (Figure 2.7). Intra- and inter-observer variability for 
estimation for measurements of a single velocity profile is 0.9±1.1 (mean±SD) 
mmHg and 1.3±1.4 (mean±SD) mmHg, respectively (Balanos et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Tricuspid regurgitation (1) visualised in colour 
Doppler mode from an apical 4-chamber view. 
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Following proper alignment of the Doppler beam with the jet, a spectral profile is 
obtained with CWD mode and the peak velocity of the regurgitation is measured 
at the most distal part of the profile. The peak velocity is then automatically 
converted to peak pressure difference (ΔPMAX) between the right ventricle and 
the right atrium using Bernoulii’s equation. ΔPMAX is assumed to change linearly 
with systolic pulmonary artery pressure in healthy individuals, because right 
atrial pressure is believed not to vary substantially. In individual subjects, 
changes in SPAP have been shown to correlate well with changes in pulmonary 
vascular pressure measured by right heart catheterisation (Dorrington et al., 
1997), and as a result SPAP can be used as an index of PVR. 
 
Cardiac Output 
Cardiac output can also be measured non-invasively using Doppler ultrasound. 
Two separate echocardiographic measurements are required for the 
determination of cardiac output. First the velocity time integral (VTI) is 
measured from the flow across the aortic valve via a 5-chamber apical view 
(figure 2.8), and second, the diameter of the location where VTI is obtained is 
measured via a parasternal long axis view. 
 
 
Figure 2.8: The flow of 
blood exiting the heart 
through the aortic valve 
during systole, visualised 
in colour Doppler mode 
from an apical 5-chamber 
view 
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The area (A) of this site is then calculated from this diameter, assuming that the 
area consists of a circle. The VTI is measured just below the aortic orifice and it 
represents the mean distance that is travelled by the blood with each cardiac 
contraction given in centimetres. The mean velocity of the flow and the duration 
of systole are taken into account for the result. The exact location where VTI is 
measured is important because two conditions have to be met; A) the flow must 
be uniform and B) the location has to be round. 
 
Cardiac output is calculated using the equation below 
HRAVTIQ ××=&  
where HR is heart rate. 
To perform the VTI measurement the aortic valve is visualised in an apical 5-
chamber view and the flow is identified in colour Doppler format. The flow 
through the aortic valve has a moderate velocity of around 80cm/s and it is 
analysed using spectral mode to calculate the mean velocity of the jet. The 
Doppler beam is aligned with the flow and the range of investigation of the PWD 
is positioned on the ventricular side of the aortic valve. A PWD spectral trace of 
the flow through the aortic valve is obtained, and its mean velocity is calculated 
and translated automatically into distance travelled per cardiac cycle. (Lewis et 
al., 1984). Intra- and inter-observer error for measurement of cardiac output 
from a single aortic flow profile is 0.08 ± 0.05 (mean±SD) L/min and 0.12 ± 0.08 
(mean±SD) L/min, respectively (Balanos et al., 2005). 
 
Training of investigator 
It has been established that the accuracy in estimating SPAP and Q˙   by Doppler 
ultrasound is highly investigator-dependent. The main investigator for the 
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purposes of this study had undergone over 100 hours of training before 
conducting ultrasound measurements for the first study of this thesis (February-
May 2007; Chapter 3). Frequent bouts of ultrasound scanning had been taking 
place prior the conduction of the second study that involved measurement of 
SPAP and Q˙   (July-August 2008; Chapter 6). 
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  CHAPTER 3: 
THE PULMONARY VASCULAR 
RESPONSE TO THE 
SUSTAINED ACTIVATION OF 
THE MUSCLE METABOREFLEX 
IN MAN 
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3.1: ABSTRACT 
The pulmonary circulation is influenced by the autonomic nervous system, yet 
whether this is physiologically important during exercise in man is not known. 
The aim of this study was to assess the pulmonary vascular response to 
sympathoexcitation induced by the maintained activation of the muscle 
metaboreflex in the post-exercise period. Nine healthy subjects performed a 2-
minute bout of intense isometric handgrip exercise followed by circulatory 
occlusion so as to maintain the muscle metaboreflex activated for 2 minutes 
(post exercise circulatory occlusion; PECO). A control protocol was also 
undertaken. Blood pressure measurements and echocardiographically-
determined estimates of systolic pulmonary artery pressure (SPAP) and cardiac 
output, were obtained at various intervals throughout the two protocols. 
Elevations in SPAP (20.06±2.08%), cardiac output (36.04±4.97%) and mean 
arterial pressure (MAP) (25.62±3.54%) were noted during isometric exercise as 
compared to baseline (All P<0.05). Increases in SPAP and MAP persisted 
during PECO (All P<0.05), whereas cardiac output returned to resting levels. All 
data are mean ± S.E.M. Our findings suggest that the sympathoexcitation 
induced by isometric exercise affects the pulmonary circulation possibly by 
inducing vasoconstriction and/or stiffening the large conduit arteries. The 
exaggerated activation of the sympathetic nervous system that has been 
evidenced in cardiopulmonary patients could be implicated in their abnormal 
pulmonary hemodynamic responses to exercise. 
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3.2: INTRODUCTION 
Blood flow through the lungs is regulated by active and passive factors 
according to the contribution of vasomotility to the final outcome. Alternations in 
blood flow are being brought about independently of changes in vascular tone 
when passive factors come into play, whereas active factors exert their 
influence by affecting the contractile and relaxation status of vascular smooth 
muscle (Barnes & Liu, 1995). 
Activation of the sympathetic component of the autonomic nervous system 
(ANS) in animal preparations is known to influence pulmonary haemodynamics 
via either vasoconstriction-mediated increases in pulmonary vascular resistance 
(PVR) (Barman, 1995; Hyman et al., 1981; Kadowitz et al., 1973; 1974; Murray 
et al., 1986) or decreases in the compliance of large conduit arteries (Ingram et 
al., 1968; 1970; Szidon et al., 1971). These effects were attributed to the 
stimulation of α1 adrenergic receptors by neurogenically-released 
noradrenaline, while that of β2 receptors was postulated to play an opposing 
role through inducing vasodilation and / or increases in arterial compliance 
(Barman, 1995; Hyman et al., 1981; Kadowitz et al., 1973; Murray et al., 1986). 
Furthermore an interaction between stimulation of adrenergic receptors has 
been purported to contribute to the existence of basal sympathetic tone in the 
pulmonary vasculature under normal physiological conditions and in addition it 
appeared to play a part in PVR regulation during exercise in sheep (Kane et al., 
1993; 1994). 
Investigations on humans have also been supportive of the view that pulmonary 
vessels and / or haemodynamics are sensitive to sympathetic influences. PVR 
elevations were commonly observed during sympathetic activation induced by 
the cold pressor test (CPT). Yet the fact that this effect was clearly apparent 
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only when the impact of mechanical factors was prevented or reduced, made 
the generation of safe inferences concerning the physiological importance of 
sympathetic influences on the pulmonary circulation not viable (Moruzzi et al., 
1988; 1989a; 1989b). 
In contrast, the vascular and / or haemodynamic response of the systemic 
circulation to sympathoexcitation is better understood. Manipulation of the 
muscle metaboreflex / chemoreflex, in particular, has been of paramount 
importance for establishing that the activation of type IV neural afferents in the 
active muscle by various metabolites induces increases in blood pressure via 
sympathoexcitation-mediated vasoconstriction (Rowell et al., 1990; Smith et al., 
2006).  Evidence for the latter has been presented at various vascular beds, 
including the renal (Momen et al., 2003) as well as those of the active and the 
inactive muscle (Hansen et al., 1994). Moreover, reductions in the compliance 
of the conduit artery feeding the musculature of the inactive limb, but not of the 
active, were shown when the muscle chemoreflex was sustained active 
following isometric exercise (Davies et al., 2007). Data regarding the response 
of the pulmonary vasculature / haemodynamics has not been available.  
The lack of cardiac output alternations with respect to pre-exercise levels that is 
observed when the muscle metaboreflex is maintained activated in the post-
exercise period could provide the optimal environment so as to assess the 
effect of the ensuing sympathoexcitation on pulmonary haemodynamics (Bastos 
et al., 2000; Nishiyasu et al., 1994; Sinoway et al., 1989). This not only could 
potentially verify the existing evidence for an autonomic nervous contribution to 
lung blood flow regulation in humans, but it might also be of particular value in 
revealing this aspect of the ANS function under physiological conditions. 
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Therefore this study sought to examine the pulmonary vascular responses to 
the maintained activation of the muscle chemoreflex following a bout of intense 
isometric exercise. An echocardiographically-obtained estimation of systolic 
pulmonary artery pressure (SPAP) was utilized as an index pulmonary vascular 
responsiveness (Balanos et al., 2002; Dorrington et al., 1997). Based on the 
findings of Ingram et al. (1968) and Szidon et al. (1971) who reported increases 
in SPAP during sympathetic stimulation in animal preparations, we 
hypothesized that SPAP would be raised in response to the sympathoexcitation 
induced in the post-exercise period by the sustained activation of the muscle 
chemoreflex.     
 
      
3.3: METHODS 
Subjects 
Nine healthy and physically active volunteers (age 21.8 ± 6 years; mean ± SD; 
5 men, 4 women) gave written consent to take part in this study after they had 
been given detailed information on the procedures and risks. The study was 
performed according to the Declaration of Helsinki and was approved by the 
Local Ethics Committee.  
 
Preliminary session 
A preliminary session was undertaken in order to determine the suitability of 
subjects and to screen for exclusion criteria, ascertained by questionnaire, 
which comprised presence of cardiorespiratory disease, recent forearm injury or 
upper respiratory tract infection. Doppler echocardiographic visualization of 
tricuspid regurgitation was then undertaken on a specially designed couch 
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(Ergoselect 1200EL, Ergoline Gmb) which allowed for a slight rotation of the 
body towards the lateral decubitus position. If the acquired ultrasound images 
were of satisfactory quality, the maximum voluntary contraction (MVC) of the 
dominant arm was then determined by a handgrip dynamometer (Lafayette 
Instrument Company) while the participants remained in the same body 
position. Subjects were instructed to maximally squeeze on the dynamometer 
and maintain this for at least 3 seconds. The exercising arm was fully extended 
and was kept close to the body. The mean of three attempts was regarded as 
the MVC provided that they did not differ more than 10% from each other.  
 
Design of the study 
Participants who completed the preliminary trial were asked to return to the 
laboratory to carry out a control and an exercise protocol on two separate 
occasions. The duration of each visit was approximately one hour and the order 
of the protocols was randomly selected. Subjects were requested to undertake 
the two protocols at the same time of the day. Additionally they were asked to 
refrain from caffeine, alcohol and performance of physical activity 12 hours, and 
eating 3 hours, prior to each visit.  
 
At the beginning of each visit participants were prepared for monitoring of heart 
rate (ECG), respiratory frequency (pneumograph), and blood pressure (finger 
plethysmography, Portapres). Finally, a pneumatic cuff was placed around the 
upper exercising arm for subsequent occlusion of forearm blood flow (E20 
Hokanson system). Following their preparation subjects rested on the couch for 
15 minutes before measurements commenced. While the first 10 minutes of the 
resting period were completed in the supine position, the couch was slightly 
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turned sideways during the final 5 minutes. Subjects were instructed to maintain 
a self selected but constant respiratory rate throughout both protocols. This was 
aided by a continuous background sound of a metronome set at a frequency of 
60 beats per minute. In addition they were asked to remain quiet and to avoid 
performing Valsalva maneuvers during measurements. 
 
After the 15 minute rest period, baseline measurements of the ΔPMAX and 
cardiac output were obtained for five minutes. Subjects were then asked to 
squeeze the handgrip dynamometer to 50% MVC and to sustain this for two 
minutes. Visual feedback of the target force and output from the dynamometer 
was given via a monitor placed within the subject’s field of view. In the control 
trial exercise was replaced by two minutes of rest. Two seconds before the 
cessation of the exercise period (or the equivalent point in the control trial) the 
pneumatic cuff around the arm was rapidly inflated to 205 mmHg and this was 
maintained for a further two minutes (PECO period). Upon deflation of the cuff 
subjects were instructed to remain in the supine resting position for a final two 
minutes (recovery period). Blood pressure and respiratory waveforms were 
continuously measured throughout both protocols. Cardiac output and trans-
tricuspid pressure difference were measured at the time points indicated in 
Figure 3.1 during baseline, exercise, PECO and recovery periods. Details of 
these measurements are given below.   
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Echocardiography 
Echocardiographic measurements were performed using a Philips Sonos 7500 
ultrasound machine with a S3 cardiac transducer (1-3 MHz). Heart rate was also 
recorded on this machine. All measurements were obtained with the subject 
being slightly rolled towards the lateral decubitus position on the specially 
designed couch that was used in the preliminary session. Series of consecutive 
cardiac cycles for each part of the protocol were acquired and stored on VHS 
tapes. At least three but usually five beats at, or close to, end-expiration were 
analyzed off line and averaged for each measurement that was made during 
every stage of the protocol. 
Estimation of SPAP from measurement of ΔPMAX 
ΔPMAX was measured for as many cardiac cycles as possible during the correct 
phase of the respiratory cycle. These measurements were then pooled to give a 
mean value for each phase of the experiment. Adjustments to the position of the 
ultrasound beam was required to maintain good quality images and this resulted 
in some data loss for short periods of the protocol. 
 
Cardiac output. 
Cardiac output was measured for approximately 30-second periods during three 
separate sections of the baseline period, after the initial rapid rise in heart rate 
had occurred during exercise, at the end of the PECO phase and then again 
during recovery when heart rate had returned to baseline levels following 
release of the occluding cuff (figure 3.1).  
 85
Given that stroke volume (SV) equals the product of VTI and A, the ratio of SV 
to pulse pressure (SBP-DBP), which has been widely used as an index of 
systemic arterial stiffness (De Simone et al., 1999), was also derived. 
 
 
 
 
Figure 3.1. Schematic representation of the experimental protocol and 
sequence of echocardiographic measurements of SPAP and cardiac 
output. Heart rate and blood pressure were monitored continuously 
throughout the protocol. PECO, postexercise circulatory occlusion; 
SPAP, systolic pulmonary artery pressure.  
 
 
Statistical methods 
Statistical analysis of the effects of muscle metaboreflex activation on 
pulmonary haemodynamics was performed using repeated measures 2-way 
ANOVA (5x2; time vs condition). If appropriate, post hoc analysis was also 
performed at individual time points by using paired t-tests (two-tailed) that were 
adjusted for multiple corrections. A power calculation showed that our study had 
76.4% power to detect a 10% change in SPAP. The statistical package utilised 
was SPSS 14.0 (SPSS Inc., Chicago, Illinois, USA). P<0.05 was considered 
significant. Data are presented as means ± S.E.M. 
 
3.4: RESULTS 
 
Baseline values of the variables obtained at the control and exercise trial are 
presented at table 3.1. No significant differences were found. 
 86
 
 
Table 3.1: Baseline values (mean±S.E.M; n=9) of the variables studied at 
the two protocols. SPAP, systolic pulmonary artery pressure; MAP, mean 
arterial pressure; SAP, systolic arterial pressure; DAP, diastolic artery 
pressure; Q˙  , cardiac output; HR, heart rate; SV, stroke volume. 
 
 
 
 Control Exercise 
SPAP, mmHg 19.67 ± 0.56 19.61 ± 0.41 
Q˙  , L/min 4.10 ± 0.20 4.20 ± 0.20 
AP, mmHg 
g 
70.55 ± 2.51 74.29 ± 4.66 
M 91 ± 3.26 93 ± 4.01 
SAP, mmHg 136 ± 5.77 136 ± 5.78 
DAP, mmH 69 ± 2.95 71 ± 3.73 
SV, ml 
HR, bpm 58 ± 1.73 57 ± 1.71 
 
 
ystolic pulmonary artery pressure 
o significant changes from baseline were noted at any stage during the control 
rial SPAP was increased by 20.06±2.08% 
 
S
N
trial. In contrast, at the exercise t
during isometric handgrip exercise and remained elevated during the first 
(+16.19±1.45%) and the second (+16.03±1.36%) minute of PECO as compared 
to the resting values (All P<0.05). SPAP gradually returned towards baseline 
levels during the recovery period (Figure 3.2 and Table 3.2).   
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Figure 3.2: Percent changes in SPAP (circles) and SAP (triangles) from 
rest during the isometric handgrip exercise (closed symbols) and control 
(open symbols) protocols. ‘*’ signifies P<0.05 compared to rest. Data are 
means±S.E.M; N=9.  
 
 
Cardiac output, heart rate and stroke volume 
Cardiac output, heart rate and stroke volume were not different from baseline at 
any time during the control trial (Figure 3.3). In the exercise trial, a 36.04±4.97% 
(P<0.05) increase in cardiac output was observed during IHG. This was due to 
a rise in heart rate (P<0.05), since stroke volume was not significantly elevated 
with respect to the initial values. During the second minute into PECO cardiac 
output fell at resting levels (P>0.05 compared to baseline). Similarly stroke 
volume increased during the recovery period causing a non-significant 
8.05±4.40% elevation in cardiac output (P>0.05 compared to baseline). Heart 
rate did not change. 
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Figure 3.3: Changes in cardiac output (top panel), heart rate (bottom left 
panel) and stroke volume (bottom right panel) during the isometric 
handgrip exercise (black bars) and control (white bars) trials. ‘*’ signifies 
P<0.05 compared to rest. Data are means±S.E.M; N=9.  
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Systemic blood pressure 
The response of mean blood pressure during the exercise trial is illustrated in 
figure 3.2. Mean, systolic and diastolic arterial pressures significantly increased 
during exercise (all P<0.05 vs rest). Subsequently they all remained elevated 
above resting levels during the first (all P<0.05) and the second (all P<0.05) 
minute into PECO. During the first minute of the recovery stage systemic 
arterial pressures decreased yet they were significantly greater as compared to 
baseline (all P<0.05). The second minute was characterised by further pressure 
decreases. 
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Table 3.2: Measurements obtained during the isometric handgrip exercise trial. For 
abbreviations see table 1 (means±SEM; n=9; “*” signifies P < 0.05 compared to rest). 
 
 Rest Exercise PECO1 PECO2 Recovery1 Recovery2 
 
SPAP, mmHg 19.61 ± 0.41 23.36 ± 0.68* 22.80 ± 0.66* 22.76 ± 0.59* 20.37 ± 0.58 19.93 ± 0.45 
  
Q˙  , L/min 4.22 ± 0.21 5.75±0.37*  4.38±0.16 4.51±0.15  
  
MAP, mmHg 93.18±4.01 116.86±5.64* 116.46±6.83* 118.97±5.95* 105.41±5.67 99.98±5.38 
  
SAP, mmHg 136.43±5.03 163.69±6.72* 168.01±7.46* 169.52±7.00* 156.76±7.23 148.14±7.98 
  
DAP, mmHg 71.59±3.74 93.48±5.24* 90.73±6.69* 93.73±5.75* 79.77±5.39 75.94±4.69 
  
SV, ml 74.44 ± 4.67 75.63 ± 3.77  76.85 ± 4.15 80.66 ± 3.74  
  
HR, bpm 57.66 ± 2.34 77.69 ± 3.77*  58.30 ± 3.28 56.80 ± 2.32  
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Systemic arterial stiffness 
The ratio of stroke volume to pulse pressure was significantly reduced during 
exercise and it remained lower than resting levels during PECO (all P<0.05). In 
contrast systemic arterial stiffness did not significantly change during the control 
trial (Figure 3.4). 
 
Figure 3.4: Changes in systemic arterial stiffness during the isometric 
handgrip exercise (black bars) and control (white bars) trials. “ * “ 
denotes P<0.05 compared to rest. Data are means±S.E.M; N=9. 
 
 
Respiratory frequency 
 
Respiratory frequency was not different between rest, PECO and recovery in 
the control and exercise trials. During exercise respiratory frequency could not 
be accurately determined because of inadvertent performances of the Valsalva 
manoeuvre and irregular breathing especially towards the end of the exercise 
bout. 
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3.5: DISCUSSION 
A ~20% increase in SPAP was observed along with an elevation in cardiac 
output during the performance of intense isometric handgrip exercise. This 
increase in SPAP was sustained during PECO, despite cardiac output returning 
to resting values. Therefore these findings suggest that the pulmonary 
vasculature is responsive to muscle metaboreflex-mediated sympathoexcitation.  
Studies on sheep have shown the existence of a high degree of α and β 
adrenergic-mediated tone in the pulmonary circulation during treadmill exercise, 
yet it was concluded that the net vasoactive effect of this adrenergic influence 
was neutral (Kane et al., 1993; 1994). On the contrary, in man concurrent 
elevations of plasma noradrenaline and pulmonary artery pressure observed 
during exercise suggest a possible SNS contribution in pulmonary 
hemodynamics (Richards et al., 1986). In the present study, using SPAP as an 
index of pulmonary vascular reactivity (Balanos et al., 2005; Grϋnig et al., 2000) 
the observed increases in SPAP during PECO identify, for the first time, a role 
for the muscle metaboreflex in the regulation of the pulmonary circulation.  
The notion that the pulmonary circulation is affected by sympathoexcitatory 
stimuli is supported by studies that show PVR increases of approximately 50% 
(Moruzzi et al., 1988, 1989a) and 20% (Moruzzi et al., 1989b) above baseline 
during cold pressor testing. Importantly, performance of the cold pressor test did 
not alter cardiac output.  In fact the latter findings were obtained under 
conditions of constant but reduced cardiac output throughout the protocol, 
brought about by inflation of a balloon in the vena cava. When blood flow was 
unimpeded, non-significant (Moruzzi et al., 1989a, 1989b) or only small (~10%) 
(Moruzzi et al., 1988) elevations in PVR were shown during the CPT. It was 
argued that the observed increases in PVR were due to pulmonary venous 
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and/or arteriolar constriction, which was potentiated by the restriction of cardiac 
output (Moruzzi et al., 1988).   
The maintenance of heightened SPAP along with the return of cardiac output to 
baseline levels noted during the PECO period in the present experiment implies 
that vascular constriction-mediated increases in PVR took place. Although the 
location of constriction at the pulmonary vascular tree could not be determined 
by our measurements, it is tempting to speculate that vessels of small diameter 
played an important role in the observed augmentation in resistance. This 
suggestion has been shared by a number of authors (Daly et al., 1970; 
Kadowitz et al., 1974), on the basis that arteries and/or veins of small diameter 
are equipped with abundant smooth muscle and consequently have a greater 
capacity to constrict as compared to large vessels (Spencer & Leof, 1964). 
This is in line with observations on steadily-perfused canine preparations in 
which responses to sympathetic stimuli were characterised by SPAP elevations 
and evidence for raised arterial stiffness of large pulmonary conduit arteries 
(Ingram et al., 1968; Szidon & Fishman, 1971). Studies on pulsatile 
hemodynamics have concluded that SNS stimulation-associated decrements in 
the compliance of large proximal arteries represent an additional opposition to 
right ventricular outflow by means of hindering the ability of the vessels to 
accommodate the output of the right ventricle without necessitating large rises 
in pressure (Piene, 1976; 1986). Interestingly, it has been experimentally shown 
that this negative influence is ameliorated when increases in pulmonary blood 
flow cause distention of the vessels (Piene, 1976). We observed that the ratio of 
stroke volume to pulse pressure was higher during PECO as compared to rest 
in agreement with results from previous reports (Davies et al., 2007; Edwards et 
al., 2008).  This information, along with our SPAP data and studies showing 
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increases in the resistance to flow in the renal (Momen et al., 2003) and the 
inactive muscle (Hansen et al., 1994) circulation during PECO collectively 
suggest that activation of type IV neural afferents in the muscle results in 
widespread arterial stiffening and/or constriction. 
Arterial stiffening in the pulmonary circulation induced by SNS activation might 
serve to protect the vessels during the usually accompanying elevations in 
cardiac output by setting a limit for distension (Dowing & Lee, 1980). This could 
maintain pulmonary blood flow within narrow limits during exercise and in 
conjunction with constriction of smaller arteries might be involved in the control 
of blood distribution within the lungs (Elkins & Milnor, 1971; Ingram et al., 1968). 
Additionally, the generation of high-pressure pulses towards the capillaries that 
is favoured from SNS-induced changes in compliance and small artery 
vasomotion coupled to the elevation in right ventricular stroke volume, has been 
postulated to account for the increased red cell velocity and the drop in transit 
time seen during exercise (Grover et al., 1983). 
On the contrary, the exaggerated resting and exercise SPAP (Himelman et al., 
1989) and PVR (Barberà et al., 2003) that characterise pulmonary hypertension 
could be partly related to the stiffer proximal pulmonary arteries that have been 
documented in these patients as compared to normotensives (Haneda et al., 
1983; Laskey et al., 1993; Reuben, 1971). Along the same lines, the 
development of high pressures in the pulmonary circuit could be favoured by 
the muscularisation of small arteries that is seen in pulmonary hypertension 
(Wagenvoort & Wagenvoort, 1983). Haneda et al (1983), who found that 
oxygen administration in the pulmonary hypertensive patients caused increases 
in large artery compliance and falls in plasma noradrenaline levels, suggested 
that the effects of hyperoxia may be attributed to low sympathetic tone. As a 
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result, increased attention has been recently given to the contribution of 
neurohumoral activation to the systemic manifestations of chronic lung disease, 
which is characterised by increased SNS activity (Andreas et al., 2005; Salvi et 
al., 1999; Velez-Roa et al., 2004). Likewise, implications might also concern 
other high-SNS activity / pulmonary hypertensive conditions such as chronic 
heart failure and high altitude pulmonary oedema (HAPO) (Cohn et al., 1984; 
Duplain et al., 1999). Markedly, a high correlation (r=0.83) was noted between 
muscle sympathetic nerve activity and SPAP in HAPE susceptible individuals 
(Duplain et al., 1999). 
In estimating SPAP we assumed a value for RAP based on the literature 
(Grϋnig et al., 2000) and that this would be unchanged throughout the protocol. 
Since isometric handgrip exercise has been associated with a small (~1-
2mmHg) elevation in RAP (Freyschuss, 1970) in some subjects this assumption 
may lead to a slight underestimation of SPAP in those who respond in this 
manner.  In favour of the latter postulation have been animal data in which 
muscle metaboreflex activation during exercise was shown to elicit increases in 
RAP (Sheriff et al., 1998). However, a possible underestimation of SPAP during 
PECO in the present study would further strengthen our conclusions rather than 
negatively affect them.   
Tidal volume was not measured in this study and its influence on the observed 
pulmonary haemodynamic changes could not be excluded during exercise 
(Jones et al., 2004). However, subjects were continuously monitored to avoid 
Valsalva manoeuvres and comparable breathing patterns and respiratory 
frequencies were achieved throughout the duration of the two protocols. In 
addition, the SPAP responses to isometric exercise observed in this study are 
similar to previously published data that were obtained invasively (Raynolds et 
 96
 
al., 1995). Anyhow the novel finding of this investigation, which is the 
maintenance of elevated SPAP in response to the activation of the muscle 
metaboreflex in the post-exercise period, is unlikely to be associated to 
respiratory changes given that ventilation during PECO is known to return to 
pre-exercise values (Houssiere et al., 2006; Iellamo et al., 1999; Lykidis et al., 
2009; Wiley & Lind, 1971). 
In summary, isometric exercise-related elevations in SPAP were sustained 
during PECO indicating that muscle metaboreflex induced sympathoexcitation 
caused pulmonary vasoconstriction. This finding might be implicated in the 
exaggerated pulmonary haemodynamic responses to exercise seen in chronic 
lung and heart sympathoexcitatory conditions. 
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CHAPTER 4: 
EFFECTS OF INCREASED 
METABOLIC RATE ON THE 
VENTILATORY SENSITIVITY TO 
INHALED CO2 
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4.1: ABSTRACT 
The role of hypermetabolism in the mediation of exercise hyperpnoea is 
contentious. Animal data evidenced that the carotid body could be directly 
involved in establishing the hyperpnoea via a metabolic rate (MR)-induced 
elevation in the ventilatory sensitivity to CO2. An increase in the 
chemosensitivity to CO2 in response to raised MR has been also evidenced yet 
this finding might be limited to the responses of central chemoreceptors. 
Therefore we aimed to assess the effect of hypermetabolism on 
chemosensitivity as it modulated by both central and peripheral receptors. 
Eight healthy subjects undertook two randomly assigned trials; in one trial the 
ventilatory response to a five-minute hypercapnic ramp (PETCO2 = 0 to 8 mmHg 
above normal; PETO2 = 100mmHg) protocol was measured prior and 210 
minutes after the ingestion of a fixed amount of beef steak fillet. In the other 
trial, the ventilatory response to the hypercapnic ramp was assessed at 0 and 
210 minutes with subjects ingesting small amounts of food at regular intervals. 
MR was measured as oxygen consumption prior to each challenge of 
hypercapnia during both trials.  
At 210 minutes MR was significantly increased by meat ingestion (0.23±0.02 to 
0.30±0.02 L/min) whereas it did not change during the control trial (0.23±0.02 to 
0.25±0.02 L/min). The ventilatory sensitivity to CO2 was increased significantly 
in the former (1.13±0.21 to 1.89±0.18 L/min/mmHg; P<0.05), but not in the latter 
trial (1.22±0.20 to 1.52±0.18 L/min/mmHg; P>0.05).  
Our results suggest that the hypermetabolism-induced increases in the 
ventilatory sensitivity to CO2 are mediated primaliry through elevations in the 
peripheral chemoreceptor gain. Enhancement of this gain appeared to be 
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facilitated even by mild increments of MR. Our findings could be involved in the 
mechanisms responsible for exercise hyperpnoea.  
 
4.2: INTRODUCTION 
Exercise hyperpnoea or the tight coupling that occurs between systemic 
metabolism and ventilation during exercise is considered to be one of the major 
remaining challenges to understand the control of human systemic function. 
Extensive research for over a century has indicated that the mechanisms 
controlling exercise hyperpnoea involve a number of feedforward (central 
command), proportional feedback (muscle reflex and carotid chemosensory) as 
well as learned elements. However, none of these mechanisms has appeared 
to fully account for the proportional rise of ventilation and metabolism, 
suggesting a degree of redundancy in this important physiological process (Bell, 
2006; Mateika & Duffin, 1995; Mitchell & Babb, 2006; Ward, 2007; Whipp & 
Ward, 1998) 
Although the increases in VO2 (i.e hypermetabolism) represent an inherent 
adjustment to exercise, their role in the mediation of exercise hyperpnoea has 
not been elucidated. It has been long argued that exercise-induced increases in 
metabolism could be associated with increased chemosensitivity of peripheral 
and/or central chemoreceptors. This implies a higher stimulus to breathe for a 
given partial pressure of arterial carbon dioxide (PACO2), which in fact remains 
largely unchanged during exercise of intensity lower than that eliciting the 
anaerobic threshold. Dynamic exercise per se has been shown to increase the 
ventilatory chemosensitivity to inhaled carbon dioxide in many occasions 
(Bannister et al., 1954; Clark et al., 1980, Hulsbosch et al., 1981,1982; 
McConnel & Semple, 1996; Pianosi & Khoo, 1995; Pandit & Robbins, 1992; 
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Poon & Greene, 1985; Weil et al., 1972), but not always (Casey et al., 1987; 
Clark & Godfrey, 1969; Duffin et al., 1980; Kelley et al., 1982; Martin et al., 
1978). Whereas it has been thought that this lack of consensus is due to the 
different methodologies used (Poon & Greene, 1985), interestingly, all studies 
that showed negative results assessed the ventilatory responses to hypercapnia 
under a background of hyperoxia. Hyperoxia has been known to decrease the 
carotid body discharge response to carbon dioxide in animals (Figerald & Parks 
1971; Lahiri & Delaney, 1975) and also to lessen the contribution of peripheral 
chemoreceptors to the ventilatory increases in response to hypercapnia at rest 
(Dahan et al., 1990; Gelfand & Lambertsen, 1973; Lai & Bruce, 1997) and 
during exercise in humans (Forster et al., 1993). Hyperoxia has also been 
shown to decrease ventilation during exercise (Hesse et al., 1981). Studies that 
reported a failure of exercise to affect the ventilatory sensitivity to ramp 
increases of CO2 against a background of hyperoxia rather suggest that central 
chemoreceptors are not involved in exercise hyperpnea. Phillipson and co-
workers (1981) provided further support to this notion by reporting significant 
differences in the ventilatory responses to metabolic CO2 loading between 
carotid body intact and carotid body-resected sheep when animals were 
breathing a normoxic inspirate, but the responses were similar under hyperoxic 
conditions. It is well known that peripheral chemoreceptors are equipped to 
respond to quick changes in PACO2 (Dahan et al., 1990; Nye, 1990) and also 
that they contribute significantly more to ventilation when hypercapnic stimuli 
are dynamic rather than steady (O’Regan & Majcherczyk, 1982). However it 
should be kept in mind that the ventilatory response to a hypercapnic stimulus 
involves a response that arises from the ventrolateral medulla, in which signals 
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from both peripheral and central chemoreceptors are integrated (Poon & 
Greene, 1985). 
The same limitations could be also applied for studies that used hyperoxic 
hypercapnia and found that hypermetabolism increases chemosensitivity. 
Therefore Zwillich et al (1979) showed that elevations in metabolism induced by 
protein ingestion resulted in enhancements in the ventilatory sensitivity to 
carbon dioxide assessed by the Read’s re-breathing method. Recently Bin-
Jaliah et al (2005) also evidenced in rats that the ventilatory sensitivity to CO2 
was increased in response to hypermetabolism. Nevertheless both 
investigations utilised hypercapnia under a background of hyperoxia, which 
could have partially silenced the peripheral chemoreceptors and consequently 
prohibiting an integrated response of the chemoreception system to evolve. 
Therefore in this study we aimed to assess whether hypermetabolism affects 
the ventilatory chemosensitivity to normoxic hypercapnia in awake humans. 
Metabolism was raised by protein ingestion and thus in absence of the other 
changes associated with exercise. Based on the findings by Zwillich et al (1979) 
and Bin-Jaliah et al (2005), we hypothesised that metabolic rate increments 
would result in enhancements in chemoreceptor sensitivity. 
 
 
 
 
 
4.3: METHODS 
 
Subjects  
Eight subjects (25.63 ±3.02 years; 5 men; 3 females) aged took part in the 
study, after they had been informed on the aims of this investigation and had 
given written consent. The experiment was approved by the local ethics 
committee. All procedures associated with the investigation were undertaken in 
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the Laboratory of Respiratory Function located in the School of Sport and 
Exercise Sciences at the University of Birmingham. Temperature in the 
Laboratory was kept at 20 C° and the light levels were constantly low. 
Participants were free from cardiorespiratory disease, non-smokers and their 
fitness status ranged from untrained to moderately-trained, as it was 
ascertained from questionnaires. They were recruited from the general 
population of the University of Birmingham and from personal contacts. Female 
subjects were asked to participate in the first 14 days of the menstrual cycle, or 
at any time if they were taking the contraceptive pill. Subjects were acquainted 
to the procedures involved in this study during a familiarisation trial.  
 
 
Trials 
After they completed the familiarization session, subjects were asked to report 
to the laboratory twice, at the same time of the day (morning to early afternoon 
hours). Visits, which were undertaken in a random order, were separated from 
each other by at least 48 hours. Participants were requested to refrain from food 
and caffeine consumption for 3 and 12 hours, respectively, prior to each visit. 
The restriction for consumption of alcohol and performance of exercise was 
applied for the 12-hour period prior to each visit.  
 
Control trials 
At start of the control trial subjects were asked to sit quietly on a chair and 
breathe through a mouthpiece that was used with a noseclip to ensure 
exclusive mouth breathing. Subjects rested for at least 15 minutes to watch 
television so that they become unaware of their breathing. During the final 5 
minutes of that period the basal values of PETCO2 and PETO2. PETCO2 and 
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PETO2 were determined. These values were used to construct the function 
according to which increases in PETCO2 (hypercapnia) in euoxia (PETO2 =100 
mmHg) would be forced later during the experiment. An initial metabolic rate 
reading was taken at zero minutes while subjects were watching television 
using a Douglas bag, dry-gas meter, vacuum pump and oxygen and carbon 
dioxide analysers. Immediately after the initial metabolic rate reading the first 
PETCO2 forcing procedure was imposed by the DEF. In the forcing procedure of 
the ramp experiment PETCO2 was initially maintained for 80 seconds at 2mmHg 
above normal as pilot data indicated that this minimised ventilatory fluctuations 
thereafter. Then PETCO2 was increased at a rate of 0.83 mmHg/min so that at 
the end of the ramp PETCO2 reached 8 mmHg above baseline. PETO2 was 
maintained at 100mmHg at all times during the ramp protocol. A schematic 
representation of the PETCO2 during the protocol is shown in figure 4.1. The 
metabolic rate readings and hypercapnic bouts were repeated at 210 minutes 
after. Subjects were administered one and a half cream crackers each hour so 
as to maintain metabolic rate at constant levels. During each of the hypercapnic 
exposures, heart rate and blood saturation were monitored to ensure the safety 
of participants. In addition during each of these exposures and metabolic rate 
measurements subjects were watching television. 
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Figure 4.1: Pattern of PETCO2 increases in the hypercapnic challenge.  
 
Steak trial  
The steak trial had an identical design to the control, with the only difference 
being that subjects ingested a lean and well-cooked beef lean steak fillet (mean 
raw weight of 545±50 grams; mean calorific value 980 kcal) immediately after 
the initial baseline metabolic rate measurement and hypercapnic exposure took 
place. Subjects were instructed to consume the food within 15 minutes. No 
crackers were administered. All other measurements were identical to the 
control protocol. 
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Metabolic rate measurements 
Metabolic rate measurements were conducted using standard indirect open-
circuit techniques (indirect calorimetry). Prior each trial the gas analyser was 
calibrated against gases of known concentrations. A mouthpiece and a noseclip 
were used to collect expired air in a Douglas bag over a period of 3 minutes. 
Collection of gases was initiated and finished at end-expiration. After the 
sample was collected the bag was agitated to ensure consistency of gas 
concentration throughout, and was analysed for volume, temperature and for 
fractions of O2 and CO2. The volume taken in acquiring the percentage 
concentrations, calculated by: flow rate (20ml/sec) x sample time (30 seconds), 
was also added to the end volume. These volumes were then converted from 
ambient temperature, pressure and saturated water vapour (ATPS) to standard 
temperature, pressure and dry (STPD). Subsequently O2 consumption (VO2) 
CO2 production, minute ventilation and non-protein Respiratory Quotitient (RQ) 
were calculated using the Haldane transformation of the Fick equation. 
 
 
Ventilatory measurements  
 
 
Given that in healthy population and at resting conditions PETCO2 approximates 
PACO2, the ventlatory responses were related to PACO2 by the equation VE= S 
(PACO2-B), where S is the slope of the response line and B is the extrapolated 
intercept on the ‘x’ axis.  
Slopes and intercepts of VE vs PETCO2 for the ramp protocol were calculated 
taking in account PETCO2 values (and their corresponding VE values) that 
ranged between 3 and 8 mmHg above normal (Figure 4.1a and 4.1b). 
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Figure 4.1: A) Example traces from one subject, showing the increase in 
PETCO2 (at top) and ventilation (bottom). B) Relationship between 
changes in ventilation and end-tidal CO2. Changes in ventilation are 
plotted as a function of changes in end-tidal CO2. A regression line has 
been fitted to the data. 
 
 
 
 
 
 
 
Statistical methods 
 
The effect of increased metabolic rate on the ventilatory chemosensitivity to 
CO2 was analysed by means of repeated measures 2-way ANOVA (2x2; time 
vs condition). If appropriate this was followed by paired t tests that were 
adjusted for multiple comparisons (SPSS 16.0). Data are expressed as means 
± S.E.M. Significance was taken at P<0.05. 
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4.4: RESULTS 
 
 
Ingestion of the beef steak brought about increases in mean VO2 (0.23±0.02 to 
0.30±0.02 L/min; P<0.0002) (Figures 4.3, 4.3b) VCO2 and RQ (Table 1). In 
contrast no significant changes in oxygen consumption were noted during the 
control trial (Figures 4.3, 4.3b). Pre-ramp mean PETCO2, which was obtained 
while subjects were breathing medical grade air, was not different compared to 
baseline between trials (Table 4.1; P>0.05). Steak ingestion induced increases 
in the slope (1.12±0.21 to 1.89±0.18 L/min/mmHg; P<0.05) but not in the 
intercept of the ventilation-PETCO2 relationship (36.82±1.02 to 37.17±0.97 
mmHg; P>0.05; Figure 4.4). Cracker ingestion had no effect on either slope 
(1.24±0.20 to 1.52±0.18 L/min/mmHg) or intercept (36.44±0.92 to 36.72±0.97 
mmHg; all P>0.05; Figure 4.4).  
 
 
 
 
 
 
 109
 
  l   l 
Table 4.1: Respiratory data obtained in the control and steak 
trials. * indicates P<0.05 versus baseline (mean±S.E.M; N=8). 
 
             Control tria Steak tria
  0 min 210 min  0 min 210 min 
 
PETCO2 (mmHg) Mean 37.05 37.32  37.65 37.74 
  SEM 1.32 0.61  1.29 1.18 
        
VCO2 (L/min) Mean 0.18 0.20  0.18 0.23* 
  SEM 0.01 0.01  0.01 0.01 
        
RQ  Mean 0.79 0.84  0.79 0.75* 
  
SEM 
 
0.01 
 
0.03 
  
0.02 
 
0.02 
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Figure 4.3: A (top panels); individual values for oxygen consumption during 
the control (left) and steak (right) trials. B (lower panel); mean (±S.E.M) 
oxygen consumption obtained during the control (open symbols) and steak 
(closed symbols) trials (N=8).  
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Figure 4.4: A (top panels); individual values for ventilatory sensitivity during 
the control (left) and steak (right) trials. B (lower panel); mean (±S.E.M) 
values for ventilatory chemosensitivity obtained during the control (open 
symbols) and steak (closed symbols) trials (N=9). 
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4.5: DISCUSSION 
 
The main finding of this investigation was that ventilatory chemosensitivity 
to normoxic hypercapnia was enhanced by mild increases in metabolic 
rate induced by ingestion. 
Our findings are in agreement with Zwillich et al (1979), who showed that 
metabolic rate increases brought about by ingestion of protein oral bolus 
induced elevations in the ventilatory chemosensitivity to hyperoxic 
hypercapnia. A high protein diet administered by intravenous infusion was 
also found to increase the ventilatory sensitivity to hypercapnia in patients 
with nutritional depletion compared to a low protein diet (Askanazi et al., 
1984). This effect of protein could be associated with its ability to induce a 
higher thermal effect as compared with the other nutrients (Dagenais et 
al., 1966; Nair et al., 1983; Raben et al., 2003; Robinson et al., 1990). In 
close relation to these results it has been evidenced that ventilatory 
sensitivity is elevated in hypermetabolic states (Engel & Ritchie, 1971; 
Zwillich et al., 1978) and decreased in hypormetabolic states (Zwillich et 
al., 1975). Specifically in hyperthyroidism, the increased respiratory 
response to hypercapnia was attributed to the increased 
adrenosympathetic activity and increased plasma catecholamine levels 
seen in this condition (Engel & Ritchie, 1971).  It has been also long 
known that either catecholamines (Cunningham et al., 1958; Maskell et al., 
2006) or increased sympathetic nervous system activity (Acker & 
O’Regan, 1981; O’Regan, 1981) can enhance the sensitivity of the carotid 
body to CO2. 
It is established that ingestion of protein is followed by sympathoexcitation 
that is evident several hours in the post-prandial state and serves the 
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maintenance of cardiac output in face of mesenteric vasodilation. The 
degree of postprandial sympathoexcitation has been shown to be directly 
related to the calorific value of the meal (Diamond and LeBlanc, 1987; 
Soucy & LeBlanc 1999; Van Baak, 2008). Although there are no available 
data to support that protein ingestion elicited sympathoexcitation in our 
experiment, we are confident that ingestion of a 580 g steak with a calorific 
value of approximately 980 kcal was enough to induce postprandial 
sympathetic activation. Against the notion that ingestion-induced 
sympathoexcitation results in elevated chemosensitivity, Zwillich et al 
(1979) observed unchanged cardiovascular variables yet enhanced 
ventilatory responses to hypercapnia following administration of a protein 
bolus. This lack of cardiovascular change in that study might be related to 
the reduced palatability of the protein bolus (Le Blanc & Brondel, 1985). 
Bin-Jaliah et al (2005) showed increases in chemosensitivity after 
metabolic rate was raised by insulin infusion, which has been known to 
elevate SNS activity (Fagius et al., 1986). Bin-Jaliah et al (2005) noted this 
increase only in carotid body-intact animals but not in the carotid-resected 
ones, and consequently they suggested that the carotid body was involved 
in the mediation of elevated chemosensitivity. A role of the carotid body in 
sensing metabolism and adjusting ventilation has been also apparent in an 
earlier study, which reported that the ventilatory response to venous VCO2 
loading in carotid body-denervated sheep was markedly reduced as 
compared to the carotid body intact animals (Phillipson et al., 1981). 
Therefore it is likely that the increases in metabolism brought about by 
protein ingestion might have increased the sensitivity of the carotid body to 
CO2.  On a theoretical basis, our postulation is also in line with the widely 
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supported ‘oscillations hypothesis’, which proposes that the rate sensitivity 
of the carotid body to changes in metabolic rate could account for the 
precise matching of ventilation and carbon dioxide production at rest and 
during exercise (Mateika & Duffin, 1995; Saunders 1980).  
The ventilatory chemosensitivity increases we observed could also be 
accounted for by increases in circulating potassium concentrations usually 
seen after protein ingestion (Kontessis et al., 1990; Zwillich et al., 1979). 
Increased blood K+ has been known to stimulate the carotid body (Band et 
al., 1985) and has attracted considerable attention as a candidate for 
exercise hyperpnea (Paterson, 1992). Against the role of potassium in 
hypermetabolism-mediated increases in CO2 chemosensitivity have been 
the results by Bin-Jaliah et al (2005), who noted decreases in circulating 
potassium along with increased chemosensitivity following increases in 
ventilation. Whereas insulin infusion has been known to decrease plasma 
potassium via an α-adrenoreceptor mechanism (Fisher et al., 1991; 
Strakosch et al., 1976) it is established that during exercise there is a 
catecholamine-driven suppression of insulin secretion (Galbo et al., 1977) 
and an increase in potassium blood levels (Paterson, 1992). 
Alternatively, the ventilatory sensitivity to CO2 we observed post-protein 
ingestion could also be accounted for by increases in body temperature 
(Vejby-Christensen and Petersen, 1973) that are commonly (Brundin & 
Wahren, 1994; Burton & Murlin, 1935; Johnston et al., 2002), but not 
always (Zwillich et al., 1979), observed post-feeding. Nevertheless the 
increases elicited by digestion are usually small as compared to that 
needed in order to induce a significant ventilatory increment at rest (>1°C) 
(White, 2006). Finally plasma concentrations of growth hormone, which 
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have been seen to increase after protein ingestion (Sukkar et al., 1968), 
could have contributed to the elevation we observed in ventilatory 
chemosensitivity (Grunstein et al., 1994).  
It has been shown that ventilatory chemosensitivity increases at the 
transition of rest to exercise, or early during exercise, and then it plateaus 
(Weil et al., 1972) or even decreases (Clark et al., 1980) as the maximal 
capacity is approached.  Increases of 253% and 130% in metabolic rate in 
these experiments elicited elevations of 30% (Clark et al., 1980) and 55% 
(Weil et al., 1972) in VE/PACO2 slope, respectively. The ~20% increase in 
metabolic rate after protein ingestion in our subjects raised 
chemosensitivity from 1.12 to 1.89 L/min/mmHg (approximately 70%). A 
comparison between slopes obtained from exercise slopes and our data 
may not be valid since we raised metabolic rate independently of limb 
movement (Biscoe & Purves, 1967) and exercise-related mental factors 
(Shea, 1996) that could influence ventilation and/or chemosensitivity.  Our 
results are comparable with these from Zwillich et al (1979) who showed 
that a ~10% elevation in metabolism induced an increase in 
chemosensitivity from 2.8 to 3.6 L/min/mmHg (about 30%). The 
appreciably lower slope values we reported could be due to the measures 
that we took in order to minimise the anxiety associated with CO2 
inhalation. Therefore we had familiarised our subjects to the procedures 
prior to the experimental day and in addition we asked them to watch 
television during measurements of chemosensitivity. A failure to address 
the anxiety factor could elevate the ventilatory response to carbon dioxide 
and yield greater slopes (Singh, 1984). Anyhow, the slopes reported in the 
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current investigation lie within previously reported ranges (Rebuck & Read, 
1971; Saunders et al., 1978). 
Our methodological approach did not fully take in account the central 
chemoreceptor constant time or the time required for ventilation to rise 
from zero to the 63% of its steady state value due to central 
chemoreceptor stimulation by CO2. Central constant time has been 
reported to range from 89 to 118 seconds (Berger et al., 1973; Gelfand & 
Lambertsen, 1973) whereas 80 seconds were allowed in the current 
investigation before the ramp increases in CO2 were forced by the DEF 
system. However, the interpretation of our results could not be confounded 
by this limitation since it was applied to all trials of this investigation. The 
increases in the ventilatory sensitivity to CO2 we observed after metabolic 
rate was elevated by food ingestion could be implicated in the 
mechanisms mediating exercise hyperpnoea. Inclusion of cardiovascular 
data, body temperature and blood analyses for catecholamines, K+ and 
acidity in this investigation would undoubtedly provide an insight on the 
mechanisms mediating the effect of increased metabolic rate. 
In summary, we observed increases in the ventilatory chemosensitivity to 
carbon dioxide in response to mild elevations in metabolic rate induced by 
protein ingestion. The effects of hypermetabolism on chemosensitivity are 
likely to be mediated by the carotid body. Our findings could be implicated 
in the mechanisms responsible for the precise matching of ventilation to 
metabolic rate at rest and during exercise. 
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CHAPTER 5: 
A RESPIRATORY RESPONSE 
TO THE ACTIVATION OF THE 
MUSCLE METABOREFLEX 
DURING CONCURRENT 
HYPERCAPNIA IN MAN 
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5.1: ABSTRACT 
 
In this study we aimed to assess the ventilatory and cardiovascular responses 
to the combined activation of the muscle metaboreflex and the ventilatory 
chemoreflex, achieved by PECO and euoxic hypercapnia (end-tidal PCO2 = 7 
mmHg above normal), respectively. Eleven healthy subjects (4 women, 7 men; 
29 ± 4.4 yrs; mean ± SD) undertook four trials, in random order; 2 minutes of 
isometric handgrip exercise followed by 2 minutes of PECO with hypercapnia, 2 
minutes of isometric handgrip exercise followed by 2 minutes of PECO while 
breathing room air, 4 minutes of rest with hypercapnia and 4 minutes of rest 
while breathing room air. Ventilation (VE) was significantly increased during 
exercise in both the hypercapnic (+3.17 ± 0.82 L/min) and the room air 
breathing trial (+2.90 ± 0.26 L/min; all P<0.05). During PECO VE returned to 
pre-exercise levels when breathing room air (+0.52 ± 0.37 L/min; P>0.05) but it 
remained elevated in hypercapnia (+3.77 ± 0.23 L/min; P<0.05). The results 
indicate that the muscle metaboreflex stimulates ventilation with concurrent 
chemoreflex activation. These findings have implications for disease states 
where effort intolerance and breathlessness are linked.  
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5.2: INTRODUCTION 
 
The involvement of muscle reflexes in the cardiovascular control during 
exercise has been established (Rowell and O’Leary, 1990). Similarly, the role of 
chemoreceptors in the regulation of ventilation at rest and during exercise has 
been also extensively appraised in the literature (Dejours, 1962; Whipp, 1994). 
In contrast, the interaction between these two mechanisms has received 
circumstantial attention (Makeham et al., 2004) although there could be 
situations in which the muscle reflexes and the chemoreceptors are operating in 
concert. 
Such a situation could be presented by CHF, in which the importance of the 
impaired reflex cardio-respiratory control system in disease progression has 
been recently emphasized (Coats, 2001). Particular consideration has been 
paid to the muscle metaboreflex, which denotes the reflex activation of 
sympathetic activity following stimulation of metabolically-sensitive receptors in 
exercising muscle, and the CO2 ventilatory chemoreflex (Schmidt et al., 2005). 
Both reflexes are overactive in CHF and the degree of their overactivation is an 
independent prognostic marker of exercise ventilatory abnormalities and 
disease status (Chua et al., 1996; Ponikowski et al., 2001). Overactivation of 
the muscle metaboreflex in CHF has been attributed to alterations in muscle 
structure and biochemistry (Piepoli et al., 1999), an impaired baroreflex function 
(Kim et al., 2005) and also the incapacity to enhance cardiac performance and 
stroke volume during exercise (Crisafulli et al., 2008). In contrast, the 
mechanisms underlying the overactivity of the ventilatory chemoreflex remain 
largely obscure (Chua et al., 1996) 
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Ponikowski et al., (2001), who evidenced that muscle metaboreflex activation 
was a strong predictor of ventilatory sensitivity to hypercapnia in CHF patients, 
argued for the existence of an interaction between the two reflexes. It was 
suggested that signals arising from metaboreceptors might interact in the 
central nervous system with input from chemoreceptors. This in turn would lead 
to an enhanced ventilatory chemosensitivity implying greater ventilation for a 
given partial pressure of PACO2. This suggestion, which has been widely 
adopted in the attempt to explain the exaggerated exercise ventilation in CHF, 
has not been experimentally verified (Chua et al., 1996; Coats, 2001; Piepoli et 
al., 1999; Schmidt et al., 2005; Tumminelo et al., 2007). Such information would 
be of importance in delineating the role of reflex cardio-respiratory control 
systems in the abnormal ventilatory responses to exercise in CHF, given that 
both the metabo- and the chemoreflex are known to be hyperactive in these 
patients. Therefore the aim of this study was to assess the respiratory and 
cardiovascular responses to the combined activation of the ventilatory 
chemoreflex and the muscle metaboreflex, achieved by hypercapnia and 
PECO, respectively, in healthy humans. Circulatory occlusion following 
isometric exercise has been known to maintain the elevated sympathetic 
activation seen during exertion without having an effect on ventilation, which 
returns to pre-exercise levels (Houssiere et al., 2006; Iellamo et al., 1999). 
Likewise, it has been shown that the sympathoexcitatory stimuli of lower body 
negative pressure and head-up tilt have no effect on ventilation under eucapnic 
conditions, but they significantly enhance ventilation when imposed against a 
hypercapnic background (Howden et al., 2004; Jordan et al., 2000).  Based on 
the latter findings, we hypothesised that ventilation during PECO under 
hypercapnic conditions would be greater to that seen with eucapnia, implying a 
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stimulatory effect of the combined activation of the muscle metaboreflex and the 
ventilatory chemoreflex on ventilation. 
 
 
5.3: METHODS 
 
Subjects  
Eleven healthy participants (4 women, 7 men; 29 ± 4.4 yrs; mean ± SD) took 
part in this study. All participants had received verbal and written instructions on 
the experimental procedures before they gave informed written consent. The 
investigation was performed according to the Declaration of Helsinki and was 
approved by the Local Ethics Committee. Selection of hypercapnic and exercise 
intensity levels that were utilised in the procedures, had been made during pilot 
work based on reports of minimum discomfort by participants. Participants were 
not taking any medication, were non-smokers and underwent a preliminary trial 
during which they became familiarised to the procedures of the study. Female 
participants were asked to participate during the follicular phase of their 
menstrual cycle. All experimental procedures took place in our laboratory at 
which temperature was kept at 21°C. 
On the experimental day, participants reported to the laboratory having 
abstained from consumption of food and caffeine-containing beverages for 4 
hours. Restriction for performance of strenuous physical activity and 
consumption of alcohol was also applied for 12 hours prior to the visit. Upon 
reporting to the laboratory, participants assumed a seated position and were 
asked to breathe through a mouthpiece that was used with a nose clip. The 
MVC force of the forearm muscles at the dominant arm was then measured in 
triplicate by a handgrip dynamometer (Lafayette Hand Dynamometer; model 
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70718; Lafayette Instrument Company). Subjects were instructed to maximally 
squeeze the dynamometer and maintain this force for 3 seconds with their 
dominant hand. The mean of the three maximal contractions was regarded as 
the MVC, provided that they were not different by more than 10%. Participants 
continued to rest quietly in the seated position for 15 minutes in order for the 
normal PETO2 and PETCO2 to be determined. During this 15 minute period 
subjects were watching television so that they became unaware of their 
breathing. Respired gas was sampled continuously via a catheter attached to 
the mouthpiece and analysed for PCO2 and PO2 by a mass spectrometer 
(AirSpec 2000, Case Scientific, London, UK). Partial pressures of O2 and CO2 
were sampled by a computer and breath-by-breath end-tidal gases were 
identified and recorded with the use of dedicated software.  
 
Trials 
Participants then undertook four trials in a random order. The trials were 
separated by 30 minutes of rest. A schematic representation of the four trials is 
shown in Figure 5.1. Before each trial and whilst subjects were breathing room 
air, one minute of resting ventilatory and cardiovascular data was recorded for 
baseline purposes. The four trials which then followed were: i) CHEMO, during 
which the ventilatory chemoreflex was investigated by exposing the participants 
to euoxic hypercapnia (PETO2=100 mmHg, PETCO2=7 mmHg above normal) 
whilst they rested for 12 minutes, ii) ERGO, during which participants breathed 
room air whilst they performed 2 minutes of isometric handgrip exercise at 40% 
of the MVC followed by a further 2 minutes of PECO, iii) CHEMO+ERGO, 
during which participants were exposed to euoxic hypercapnia (PETO2=100 
mmHg, PETCO2=7 mmHg above normal) whilst they performed 2 minutes of 
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isometric handgrip exercise followed by a further 2 minutes of PECO, and iv) 
CONTROL, during which participants breathed room air whilst they rested for 
12 minutes. All trial periods were followed by 2 minutes of recovery data 
collection before the rest period began. 
To ensure that steady state had been achieved in the ventilatory response to 
euoxic hypercapnia in the CHEMO and CHEMO+ERGO trials, a period of 8 
minutes was allowed before any further intervention was performed. An 8-
minute period was also applied to ERGO and CONTROL trials for consistency. 
Subjects were instructed to breathe normally without performing abnormal 
respiratory manoeuvres at all times. Subjects were watching television at all 
times except during exercise. 
 
 
Figure 5.1: Schematic representation of the protocol. ‘EX’ signifies 
period of isometric forearm exercise. Arrows indicate 1-minute 
periods over which measurements of ventilation, blood pressure 
and heart rate were averaged. 
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Isometric exercise and PECO 
During handgrip exercise participants had visual feedback from a monitor in 
order to maintain force output as close to the predetermined 40% of their MVC 
as possible. This relative tension was chosen because it was associated with 
minimal discomfort when PECO was superimposed to hypercapnia in 
preliminary trials, while facilitating the ischaemic conditions required for 
activation of the muscle metaboreflex (Houssiere et al., 2006; Zwartz et al., 
2004) Participants were asked not to tense any other muscles apart from those 
of the forearm, and in addition not to stop squeezing the handgrip dynamometer 
at any time during exercise to prevent metabolite release into the systemic 
circulation and a diminished activation of the muscle metaboreflex during the 
subsequent PECO. PECO was induced 5 seconds prior to the cessation of 
exercise by rapid inflation to 200mmHg of a pneumatic cuff around the upper 
arm (E20 Hokanson System, Hokanson, Bellvue, USA).  
 
 
Cardiovascular measurements 
Mean arterial pressure (MAP) and HR were measured continuously using finger 
photoplethysmography (Portapress, Finapress Medical Systems, the 
Netherlands) and a three-lead ECG (Micromon 7141 monitor, Kontron Medical, 
France), respectively. The middle finger of the non-exercising arm, which was 
rested at heart level, on the armrest of the chair, was used for measurement of 
blood pressure. The blood pressure and ECG signals were sampled by an 
analog-to-digital converter (Cambridge Electronic Design 1401 plus, 
Cambridge, UK). Data were recorded and displayed using Spike 2 software 
(Cambridge Electronic Design, Cambridge, UK).  
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Spontaneous baroreflex sensitivity (SBRS) at the operating point of the 
baroreflex function curve was assessed offline using the sequence technique, 
which involved detecting sequences of three or more successive beats where 
systolic blood pressure and RR interval were either both increasing or both 
decreasing. Regression equations from these sequences of systolic blood 
pressure (x-axis) and RR interval (y-axis) provided slope values representative 
of SBRS and provided intercept values (Iellamo et al., 1999). Only those 
regressions with r2>0.95 were accepted. The minimum cut-off number of 
sequences for inclusion in analysis was 3 per time interval. 
 
Measurements 
Ventilation, blood pressure (Portapress, Finapress Medical Systems, The 
Netherlands) and HR were continuously recorded throughout the duration of the 
protocol. Minute averages were calculated for baseline, steady state, second 
minute into exercise, second minute of PECO and second minute of recovery. 
 
 
Statistical methods 
Differences between baseline values across trials were tested by means of one-
way ANOVA for repeated measures. Local weighted scatter plot smoothing was 
applied in the mean ventilation curves from baseline until the end of steady 
state for the CHEMO and CHEMO+ERGO trials. This revealed the same 
distinct ventilatory pattern in both trials; one steep increase followed by a 
plateau, which was maintained until the end of the exposure , verified that 
steady state was achieved within approximately 5 minutes. This is in 
accordance with the results from Berkenbosch et al (1989) who, similarly to the 
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present investigation, used end-tidal forcing to induce hypercapnia. Two-way 
ANOVA for repeated measures were used to examine differences between 
trials. When appropriate, multiple-comparison adjusted post hoc tests were then 
applied to reveal differences.  Data are expressed as means ± S.E.M. and 
significance (P<0.05) was tested by means. All statistical analysed were 
conducted by using a standard statistical package (SPSS, Chicago, IL). 
 
 
5.4: RESULTS 
 
Changes taking place from baseline to steady state 
Mean respiration, HR and MAP values at baseline and steady state are 
presented in table 5.1. When breathing room air, no significant differences in 
ventilation were observed between baseline and steady state values in the 
ERGO and CONTROL trials, and HR and MAP values during steady state were 
also unchanged from those at baseline (P>0.05).  However, exposure to euoxic 
hypercapnia caused minute ventilation, to almost double from baseline levels, at 
steady state, in both the CHEMO and CHEMO+ERGO trials. The slight 
increases in mean HR and MAP noted during steady state compared to 
baseline in these latter two trials were not significant (MAP; P=0.073, HR; 
P=0.17
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Table 5.1: Mean values for measurements taken before any intervention (baseline) and after eight minutes of rest 
(steady state) under conditions of either room air breathing (CONTROL and ERGO trials) or euoxic hypercapnia 
(CHEMO and CHEMO+ERGO trials). # signifies significant difference from baseline levels; P<0.001, N=11. 
 
 
 
CONTROL 
 
CHEMO 
 
ERGO 
 
CHEMO+ERGO
 
 
 
VE (L/min) 
 
 
Baseline 
 
Steady state 
 
8.13 ± 0.59 
 
8.26 ± 0.54 
 
9.10 ± 0.66 
 
19.53 ± 1.00# 
 
8.23 ±  0.63 
 
7.94 ± 0.57 
 
9.17 ± 0.58 
 
19.22 ± 1.04# 
 
 
 
MAP (mmHg) 
 
 
Baseline 
 
Steady state 
 
 
93 ± 3.8 
 
96 ± 4.0 
 
96 ± 2.5 
 
103 ± 3.4 
 
96 ± 2.8 
 
97 ± 2.7 
 
92 ± 4.8 
 
98 ± 4.9 
 
HR (bpm) 
 
 
 
Baseline 
 
Steady state 
 
65 ± 2.5 
 
66 ± 2.3 
 
66 ± 3.3 
 
70 ± 3.5 
 
63 ± 2.9 
 
64 ± 2.9 
 
68 ± 3.8 
 
71 ± 4.3 
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Changes with respect to steady state 
Any further changes from the steady state values that were induced in 
ventilation during each of the trial conditions are shown in Figure 5.2. Exercise 
while breathing room air (ERGO trial) induced a significant increase of 2.90 
L.min-1 in ventilation compared to steady state.  Exercise under hypercapnic 
conditions (CHEMO+ERGO trial) also brought about a similar, significant, 
increase in ventilation (~3 L/min) compared to steady state. However, during 
PECO, in the ERGO trial VE fell back to steady state levels (P>0.05 vs steady 
state) but in the CHEMO+ERGO trial, VE remained elevated at the levels seen 
during exercise throughout this phase of the experiment (P<0.05 vs steady 
state) (see Figure 5.2). During the Recovery phase of the ERGO and 
CHEMO+ERGO trials, VE was not significantly different from steady state 
values (P>0.05). In the CHEMO and CONTROL trials ventilation was not further 
altered from steady state values, during any phase of the trials.   
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Figure 5.2: Change in minute ventilation from steady state values during 
each phase of the hypercapnic, CHEMO+ERGO (closed circles) and 
CHEMO trials (closed triangles) and the air breathing, ERGO (open 
circles) and CONTROL (open triangles) trials. Mean ± S.E.M, N=11. * 
denotes significant difference from steady state value, # denotes 
significant difference between CHEMO+ERGO vs ERGO trials; P<0.05. 
 
 
Changes from steady state values, in MAP and HR which were seen during 
Exercise, PECO and Recovery in the four trial conditions are also shown in 
Figures 5.3 and 5.4, respectively. Exercise induced similar significant increases 
in MAP from steady state values in both the ERGO and CHEMO+ERGO trials. 
During PECO, MAP showed the expected fall from end Exercise levels but 
remained significantly elevated above steady state values by 16-19 mmHg in 
both trials. Importantly, there was no significant difference between the blood 
pressure responses to PECO in the two trials (see figure 5.3).  HR was also 
elevated during Exercise in both the ERGO and CHEMO+ERGO trials by 
approximately 10bpm but it promptly returned to steady state levels during 
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PECO in both trials (see Figure 5.4). During Recovery in both the ERGO and 
CHEMO+ERGO trials MAP and HR were not different compared to steady state 
(all P>0.05). MAP and HR in the CHEMO and CONTROL trials were not 
significantly altered compared to steady state at any point and there were no 
significant differences between these hypercapnic and air breathing trials. 
 
 
Figure 5.3: Change in mean arterial pressure from steady state values 
during each phase of the hypercapnic, CHEMO+ERGO (closed circles) 
and CHEMO trials (closed triangles) and the air breathing, ERGO (open 
circles) and CONTROL (open triangles) trials. Mean (±S.E.M), N=11. * 
denotes significant difference from steady state value; P<0.05. 
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Figure 5.4: Change in heart rate from steady state values during each 
phase of the hypercapnic CHEMO+ERGO (closed circles) and 
CHEMO trials (closed triangles) and the air breathing, ERGO (open 
circles) and CONTROL (open triangles) trials. Mean (±S.E.M), N=11. * 
denotes significant difference from steady state value; P<0.05. 
 
 
Our criteria for SBRS analysis were met in only four subjects. The mean slope 
of the SBP versus RR interval regression was reduced during exercise under 
either hypercapnic or room air breathing conditions, although this was not 
significant (Figure 5.5). During the circulatory occlusion period the slope 
remained decreased in the hypercapnic trial whereas it was elevated above 
steady state levels while breathing room air (both P>0.05). The mean intercept 
of the regression was decreased during exercise and then it returned at steady 
state levels during PECO in the CHEMO+ERGO trial (all P>0.05) (Figure 5.6). 
In the ERGO trial the mean intercept was not affected by exercise but it was 
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increased beyond steady state levels during PECO and recovery, although 
significance was not attained (all P>0.05) (Figure 5.6).  
 
 
 
Figure 5.5: Mean slope (±S.E.M) values of regression lines calculated 
from sequence analysis during the ERGO (open circles) and 
CHEMO+ERGO (filled circles) trials (N=4). 
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Figure 5.6: Mean intercept (±S.E.M) values of regression calculated from 
sequence analysis during the ERGO (open bars) and CHEMO+ERGO 
(closed bars) trials (N=4). 
 
 
 
 
5.5: DISCUSSION 
 
The main finding of the present investigation is that under conditions of 
hypercapnia, the sustained activation of the muscle metaboreflex by post-
exercise circulatory occlusion maintained the increases in ventilation at levels 
seen during exercise, whereas the same procedure in air did not maintain the 
ventilatory elevation. 
We reported that activation of the muscle metaboreflex by circulatory occlusion 
following a bout of isometric exercise did not significantly affect respiration 
under eucapnic conditions. This is in accordance to previous published data 
(Houssiere et al., 2006; Iellamo et al., 1999; Wiley & Lind, 1971). The fact that 
blood pressure and heart rate were not different between PECO in air and 
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hypercapnia, precludes the possibility that there was an enhanced muscle 
afferent feedback during PECO in hypercapnia which could explain the 
enhanced ventilation. Jordan et al (2000) also found that the 
sympathoexcitatory maneuver of head-up tilt was associated with increases in 
ventilation only during hypercapnia, but not during eucapnia. The enhancement 
in ventilation in the previous study was accompanied by attenuations in the 
hypercapnia-induced elevations in cerebral blood flow. Markedly, when the 
effect of head-up tilt and hypercapnia was studied with complete ganglionic 
blockade, diminished elevations in ventilation and enhancements in cerebral 
blood flow were observed (Jordan et al., 2000). 
These authors postulated that the observed sympathoexcitation-induced 
ventilatory increments were possibly mediated via cerebral vasoconstriction 
and/or increased peripheral chemosensitivity. It has been widely suggested that 
cerebral vasoreactivity and / or cerebral blood flow is of paramount importance 
in modulating the ventilatory response to carbon dioxide, possibly via 
influencing the gain of central chemoreceptors (Xie et al., 2005; 2006). As such, 
reduction of brain blood flow in unanesthetized goats provoked increases in the 
respiratory responses to CO2 (Chapman et al., 1979). Whether the ventilatory 
enhancement observed during superimposition of metaboreflex activation on 
that of the chemoreflex was due to a PECO-induced diminution in brain blood 
flow is unknown but possible. Against this postulation, have been data showing 
a failure of PECO to affect cerebral blood flow under conditions euoxic / 
eucapnic conditions (Jørgensen et al., 1992; Pott et al., 1997; Vianna et al., 
2009).    
On the other hand, sympathoexcitation and vasoconstriction arising from PECO 
has been evidenced at various extracranial arterial beds, including that of the 
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inactive muscle (Seals, 1989), kidney (Momen et al., 2003) and lung (Lykidis et 
al., 2008). This raises the possibility for increased carotid chemoresponsiveness 
to contribute to the increases in ventilation we observed during PECO in 
hypercapnia, given that sympathetic activation has been shown to increase the 
carotid body gain in response to carbon dioxide (Joels & White, 1968; Maskell 
et al., 2006). In addition, PECO has been found to induce increases in 
circulating renin and noradrenaline (Nishiyasu et al., 1998), the latter of which 
was shown to enhance the respiratory response to CO2 (Cunningham et al., 
1958). Renin, in turn, is converted to angiotensin II which was reported to 
increase carotid chemoreceptor afferent activity in rats (Allen, 1998) and to 
contribute to the hypercapnia-mediated ventilatory augmentations seen in 
unanesthetised dogs (Walker & Jennings, 1995). Nevertheless, our blood 
pressure data does not support an increased activation of the renin-angiotensin 
system during PECO in hypercapnia, since no difference was noted compared 
to PECO while breathing air.   
The increases in ventilation seen during PECO against a hypercapnic 
background in the present study could be also accounted for by a central 
interaction between the muscle metaboreflex and the ventilatory chemoreflex. 
Therefore neural signals from metaboreceptors that converge into the 
ventrolateral medulla could cause augmentation of chemoreceptor input and 
increase central and/or peripheral chemoreceptor sensitivity to CO2 (Clark et al., 
2000; Schmidt et al., 2005). Although to date no experimental data has been 
available to directly support this postulation, it has been shown that activation of 
the cardiac sympathetic afferent reflex in healthy and CHF rats caused an 
augmentation of the chemoreflex, with the ventrolateral medulla and the NTS 
being identified as the site of interaction (Gao et al., 2007; Wang et al., 2008). It 
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has been established that the NTS is involved in the mediation of the muscle 
metaboreflex and the cardiac sympathetic afferent reflex which have been 
known to have common activation stimuli including ischaemia, adenosine and 
capsaicin (Costa et al., 2001; Kaufman et al., 1982; Wang & Ma, 2000; Zahner 
et al., 2003). Along these lines, activation of the muscle metaboreflex might 
have also enhanced the carotid body chemoresponsiveness to CO2, underlying 
the ventilatory stimulation seen during PECO in hypercapnia in the present 
experiment. In addition, the lower mean baroreflex sensitivity during the 
hypercapnic PECO compared to that during room air breathing, although not 
being significant, depicts a partial removal of the inhibitory effect that the 
baroreflex is known to have on the ventilatory responses to chemoreflex 
activation (Somers et al., 1989; 1991).  
The ventilation enhancements we observed when the ventilatory chemoreflex 
and the muscle metaboreflex were concurrently activated could be implicated in 
the abnormal respiratory increases that characterise exercise in CHF, given that 
both reflexes are hyperactive in these patients. Along the same lines, the 
excessive muscle metaboreflex activation in this condition could increase the 
gain of central/peripheral chemoreceptors or cause them to overshoot, resulting 
in increased ventilation for a given PACO2 or VCO2 (Coats, 2001; Schmidt et al., 
2005). As a corollary to these postulations, exercise training, which has been 
known to attenuate muscle metaboreflex activation (Piepoli et al., 1996), was 
shown to diminish both exercise hyperventilation and the activity of the 
ventilatory chemoreflex in CHF patients (Tomita et al., 2003). In addition, the 
improvements in exercise ventilation observed after acute and chronic 
administration of sildenafil to these patients were strongly associated with a 
lessened metaboreflex activity. Favourable effects of sildenafil have been also 
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demonstrated for arterial function, breathlessness during exercise and 
pulmonary haemodynamics (Guazzi et al., 2007; 2008). Pulmonary 
haemodynamics, in turn, which were closely related to markers of exercise 
hyperventilation in CHF (Lewis et al., 2008; Reindl et al., 1998), appeared to be 
affected by the activation of the muscle metaboreflex in healthy humans (Lykidis 
et al., 2008). In total, the emerging importance of the overactive ergoreflex in 
the pathogenesis of abnormally high ventilation during exercise in CHF is 
further strengthened by the results of the present investigation. Nevertheless, 
the fact that we utilised healthy subjects precludes extrapolation of our findings 
to CHF and thus necessitates further experiments aiming at assessing the 
ventilatory effect of the two reflexes’ concurrent activation in CHF patients.       
 
In conclusion, we showed that activation of muscle metaboreflex activation 
against a background of hypercapnia (i.e. ventilatory chemoreflex activation) 
maintained ventilation at levels seen during exercise. We suggest that our 
findings could be implicated in the exaggerated ventilation seen during exercise 
in CHF given that both reflexes are hyperactive in this condition.  
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CHAPTER 6: 
THE PULMONARY VASCULAR 
RESPONSE TO THE 
COMBINED ACTIVATION OF 
THE MUSCLE METABOREFLEX 
AND MECHANOREFLEX 
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6.1: ABSTRACT 
The interplay between the muscle metabo- and mechanoreflex is well known to 
participate in the mediation of the cardiovascular responses to exercise. 
Whether interplay between these reflexes is operative in the control of the 
pulmonary vascular response to exercise is unknown. The aim of this study was 
to assess the pulmonary vascular response to the combined activation of the 
two muscle reflexes. Nine healthy subjects performed a bout of isometric calf 
plantarflexion exercise. During exercise and for 9 minutes post-exercise, 
circulatory occlusion was applied. At 5 minutes into PECO the calf muscle was 
stretched for 180 s. A control (no exercise) protocol was also undertaken. Blood 
pressure measurements and echocardiographically-determined estimates of 
SPAP and cardiac output Q˙ , were obtained at various intervals throughout the 
two protocols. Elevations in SPAP (22.51 ± 2.61%), Q˙  (26.92±2.99%) and mean 
MAP (15.38±2.29%) were noted during isometric exercise as compared to 
baseline (All P<0.05). Increases in SPAP and MAP persisted during PECO (All 
P<0.05), whereas Q˙  returned to resting levels. Increases in MAP and SPAP 
were also maintained during stretch which significantly elevated Q˙  (All P<0.05). 
All data are mean ± S.E.M. These data suggest that activation of the muscle 
mechanoreflex attenuated the vasoconstriction or increases in pulmonary 
vascular stiffness mediated by activation of the metaboreflex. Our findings could 
be implicated in the regulation of pulmonary haemodynamics during exercise. 
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6.2: INTRODUCTION 
It has been long believed that the regulation of pulmonary haemodynamics and 
blood flow during exercise is mediated in a passive fashion through the 
exercise-associated increases in cardiac output (Q˙ ), with the ANS exerting little, 
if at all any, influence (Mercus et al., 2008; Reeves & Taylor 1996). However, 
both sympathetic (Chand & Altura, 1980; Szidon & Fishman, 1971; Vanhoutte, 
1974) and parasympathetic (Norel et al., 1996; Toga et al., 1996; Wilson et al., 
1995) activation have been long known to be capable of influencing pulmonary 
vascular tone in isolated vessels of animals. Similar evidence has been 
generated from in various animal preparations (Barman, 1995; Duke et al., 
1960; Hyman & Kadowitz, 1988; Hyman et al., 1981; Ingram et al.,1968; 1970; 
Kadowitz & Hyman, 1973; Nandiwada et al., 1983; Piene, 1976; Porcelli & 
Bergofsky, 1973; Sada et al., 1987; Szidon & Fishman, 1971) and also in intact 
animals at rest (Kadowitz et al., 1974; Murray et al., 1986) and during exercise 
(Kane et al., 1993; 1994; Koizumi et al., 1996; Strubenitsky et al., 1998). 
Investigations on resting humans have also been supportive of the view that 
pulmonary vessels and / or haemodynamics are sensitive to neural influences 
(Moruzzi et al., 1988; 1989a; 1989b) however the exact function of the ANS in 
pulmonary vascular regulation exercise human studies has been far from clear.  
Recently, the pulmonary vascular response to the activation of the muscle 
metaboreflex was appraised in healthy humans by our working group (Chapter 
1; Lykidis et al., 2008).  We observed that the sustained activation of the muscle 
metaboreflex in the post-exercise period maintained the exercise-induced 
increases in systolic pulmonary artery pressure under conditions of resting 
cardiac output, implying increases in pulmonary vascular resistance (Lykidis et 
al., 2008). It is established that the sympathoexcitation induced by muscle 
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metaboreflex activation operates in concert with the vagal inhibition associated 
with muscle mechanoreflex activation in mediating the cardiovascular 
adjustments to exercise (Rowell & O’Leary, 1990). However the effect of their 
combined activation on pulmonary haemodynamics has not been studied in the 
literature. Such information would be useful in delineating the role of muscle 
reflex control systems in the regulation of pulmonary blood flow. In addition it 
would have implications in the exaggerated pulmonary haemodynamic 
response in CHF given that regulation of muscle metaboreflex and 
mechanoreflex are abnormal in these patients (Piepoli et al., 2008). Therefore 
we sought to assess the effect of muscle mechanoreceptor activation by 
passive stretch of the calf muscle with and without concurrent metaboreflex 
activation by PECO. Previous studies have evidenced that vagal inhibition by 
atropine caused pulmonary vasodilation when the pre-existing vascular tone 
was elevated sympathetic/parasympathetic stimulation (Vanhoutte, 1974; 
Wilson et al., 1995). Based on these findings we hypothesised that stimulation 
of the muscle mechanoreflex would offset the increases in SPAP seen during 
muscle metaboreflex activation. 
 
 
6.3: METHODS 
Subjects 
Nine healthy and physically active volunteers (age 27±3.60 years; mean ± SD;  
4 men, 5 females) gave written consent to take part in this study after they had 
been given detailed information on the procedures and risks. The study was 
performed according to the Declaration of Helsinki and was approved by the 
Local Ethics Committee. Female participants were asked to take part in the 
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procedures during the follicular phase of their menstrual cycle. All procedures 
associated with the investigation were undertaken in the Cardiovascular 
Laboratory located in the School of Sport and Exercise Sciences at the 
University of Birmingham.  
 
 
Preliminary session 
A preliminary session was undertaken in order to determine the suitability of 
subjects and to screen for exclusion criteria, ascertained by questionnaire, 
which comprised presence of cardiorespiratory disease, recent leg injury or 
upper respiratory tract infection. Doppler echocardiographic visualization of 
tricuspid regurgitation was then undertaken with subjects lying on the couch of a 
Biodex System 3 Pro isokinetic dynamometer (Biodex Medical Systems, 
Shirley, NY, USA). Cushions were placed at the right side of the back support of 
the Biodex system so that subjects’ bodies were slight rotated towards the 
lateral decubitus position. If the acquired ultrasound images were of satisfactory 
quality, subjects were asserted as eligible to take part in the study and they 
were familiarized to the procedures involved in the experimental day.   
  
Experimental day 
Participants who completed the preliminary trial were asked to return to the 
laboratory to carry out a control and an exercise protocol on the same day. 
Protocols were separated by each other by 30 minutes of rest. The duration of 
the visit was approximately one hour and the order of the protocols was 
randomly selected. Subjects were asked to refrain from caffeine, alcohol and 
performance of physical activity 12 hours, and eating 3 hours, prior to the visit.  
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At the beginning of the visit participants were prepared for monitoring of heart 
rate (ECG) and blood pressure (finger plethysmography, Finapres). Finally, a 
pneumatic cuff was placed around the lower femur for subsequent occlusion of 
leg blood flow (E20 Hokanson system). Following this subjects were asked to 
rest on the Biodex couch. Their right foot was strapped to the footplate so that 
the lower leg was horizontal to the floor and that the angle between the femur 
and the chin was 150°. Velcro straps were used to fix the foot and minimise 
heel lift during voluntary plantarflexor exercise and passive stretch. Passive 
range of dorsiflexion of the ankle joint was then established by manually moving 
the footplate as far as was comfortable. This information was programmed into 
the machine so that the Biodex could perform the subsequent stretching 
movement automatically. The MVC force of the calf plantarflexors was 
subsequently assessed by recording maximal efforts. The median force output 
was regarded as the MVC. 
 
Experimental protocol 
After the MVC was determined subjects continued resting on the couch for 15 
minutes before measurements commenced. Subjects were instructed to 
maintain a self selected but constant respiratory rate throughout the protocols. 
This was aided by a continuous background sound of a metronome set at a 
frequency of 60 beats per minute. In addition they were asked to remain quiet 
and try to avoid performing Valsalva maneuvers during measurements. 
 
After the 15-minute rest period, baseline measurements of the ΔPMAX and 
cardiac output were obtained for five minutes. At the end of this period the cuff 
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placed around the right thigh was inflated to 200mmHg by a rapid cuff inflator 
(E20, Hokanson, Bellevue, WA, USA) and this remained inflated for a further 9 
minutes. At the time of cuff inflation, subjects were instructed to either rest for a 
further 1.5 minutes (control trial), or perform ischemic isometric plantarflexion 
exercise using their right calf muscles in order to produce a force that matched 
the pre-determined exercise intensity of 50% MVC (exercise protocol) for 1.5 
minutes. Visual feedback of the target force and output from the dynamometer 
was given via a monitor placed within the subject’s field of view. After a further 
3.5 minutes of circulatory occlusion, the foot was passively dorsiflexed by the 
Biodex to the predetermined maximum pain-free angle at a velocity of 30 deg/s, 
and held there for the next 3 minutes with continued occlusion. After this stretch 
period, the foot was returned to its starting position and circulatory occlusion 
continued for a further minute. The thigh cuff was then deflated and subjects 
recovered for a further 2 minutes. 
Blood pressure and heart rate were continuously measured throughout both 
protocols. Cardiac output and trans-tricuspid pressure difference were 
measured at the time points indicated in Figure 6.1 during baseline, exercise, 
PECO and recovery periods. Details of these measurements are given below.   
 
Estimation of SPAP from measurement of ΔPMAX 
ΔPMAX was measured for as many cardiac cycles as possible at, or close to, 
end-expiration. These measurements were then pooled to give a mean value 
for each phase of the experiment. Adjustments to the position of the ultrasound 
beam were required to maintain good quality images and this resulted in some 
data loss for short periods of the protocol. 
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Cardiac output. 
Cardiac output was measured for approximately 30-second periods during three 
separate sections of the baseline period, after the initial rapid rise in heart rate 
had occurred during exercise, at the end of the PECO and stretch phases and 
then again during the second minute into recovery (Figure 6.1).  
 
 
Figure 6.1: Schematic representation of the experimental protocol. 
EXE; Exercise. 
 
 
Statistical methods 
Statistical analysis was performed using repeated measures ANOVA (5x2; time 
vs condition) and post hoc analysis using paired t-tests that were adjusted for 
multiple comparisons, when required. A power calculation showed that our 
study had 76.4% power to detect a 10% change in SPAP. The statistical 
package utilised was SPSS 14.0 (SPSS Inc., Chicago, Illinois, USA). P<0.05 
was considered as significant. Data are presented as means ± S.E.M. 
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6.4: RESULTS 
 
Baseline values of the variables obtained at the control and exercise trial are 
presented in Table 6.1. No significant differences were found. 
 
Table 6.1: Baseline mean values (±S.E.M) of the variables studied at the two 
protocols. SPAP, systolic pulmonary artery pressure; MAP, mean arterial 
pressure; SAP, systolic arterial pressure; DAP, diastolic artery pressure; Q˙  , 
cardiac output; HR, heart rate; SV, stroke volume (N=9). 
 
 Control Exercise 
SPAP, mmHg 14.62 ± 0.43 14.90 ± 0.47 
Q˙   L/min 2.96 ± 0.12 3.04 ± 0.13 
MAP, mmHg 78 ± 2.97 80 ± 3.47 
SAP, mmHg 116 ± 3.46 121 ± 5.04 
DAP, mmHg 59± 3.04 60 ± 2.83 
SV, ml 70.55 ± 2.51 74.29 ± 4.66 
HR, bpm 59 ± 2.08 61 ± 2.13 
 
 
Systolic pulmonary artery pressure 
No significant changes from baseline were noted at any stage during the control 
trial. In contrast, at the exercise trial SPAP was elevated by 22.51 ± 2.61% 
during isometric exercise and remained increased during (+15.26 ± 3.03%) 
PECO and (+13.44 ± 2.28%) Stretch compared to the resting values (All 
P<0.05). SPAP gradually returned towards baseline levels during the recovery 
period (Figure 6.2 and Table 6.2).   
Cardiac output, heart rate and stroke volume 
Cardiac output, heart rate and stroke volume were not different from baseline at 
any time during the control trial (Figure 6.3). In the exercise trial, a 26.92±2.99% 
(P<0.05) increase in Q˙  was observed during exercise. This was due to a rise in 
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heart rate (22.88±2.65%; P<0.05) since changes in stroke volume (+3.31±1.17 
%) failed to reach significance. During PECO, Q˙  fell at resting levels 
(+6.95±1.87%; P>0.05 vs baseline) and subsequently increased during stretch 
(+19.82±4.36%; P<0.05 vs baseline). This was due to a rise in both heart rate 
(10.93±2.14%; P<0.05) and stroke volume (7.87±2.64%; P=0.08). Heart rate, 
stroke volume and cardiac output all returned to baseline values during the 
recovery. 
 
Systemic blood pressure 
Systolic, diastolic and mean blood pressure values during the two trials are 
illustrated in Figure 6.4. No significant changes from baseline were noted at any 
stage during the control trial. Mean, systolic and diastolic arterial pressures 
significantly increased during exercise (all P<0.05 vs baseline). Subsequently 
they all remained significantly elevated above resting levels during PECO and 
Stretch (all P<0.05 vs baseline) with the exception of DAP (P=0.08). During 
recovery, systemic arterial pressures decreased towards baseline values (all 
P>0.05). 
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Figure 6.2: Mean percentage changes (±S.E.M) in SPAP from baseline 
during the isometric exercise (closed symbols) and control (open 
symbols) protocols (* indicates P<0.05 compared to rest; N=9).  
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Figure 6.3: Mean (±S.E.M) percentage changes from baseline in 
cardiac output (top panel), heart rate (bottom left panel) and stroke 
volume (bottom right panel) during the isometric exercise (black bars) 
and control (white bars) trials (* indicates P<0.05 from baseline; N=9). 
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Figure 6.4: Mean (±S.E.M) percentage changes from baseline in SAP 
(top left panel), DAP (top right panel), heart rate (bottom left panel) and 
MAP (bottom right panel) during the isometric exercise (closed symbols) 
and control (open symbols) trials (* indicates P<0.05 from baseline; 
N=9). 
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6.5: DISCUSSION 
A ~20% elevation in SPAP was observed along with an increase in cardiac 
output during the performance of isometric plantarflexor exercise. This increase 
in SPAP was sustained during PECO, despite Q˙  returning to resting values. 
Induction of calf muscle stretch parallel to PECO resulted in rises in Q˙  while 
maintaining the elevations in SPAP. Our findings suggest that activation of the 
muscle mechanoreceptors attenuates the elevated pulmonary vascular tone 
and/or stiffness mediated by muscle metaboreceptor activation. 
Given that activation of muscle mechanoreceptors is known to result primarily in 
vagal withdrawal, our findings resemble those obtained from various in vitro and 
in situ animal preparations, which collectively evidenced that parasympathetic 
inhibition by atropine reversed pre-existing pulmonary vasoconstriction (Altiere 
et al., 1986; Chand et al., 1980; El-Kashef et al., 1991; Hyman et al., 1988; 
Vanhoutte, 1974; Wilson et al., 1995). Although a restoration of SPAP towards 
resting levels did not take place when the mechanoreflex was activated against 
a background of activated metaboreflex, SPAP was not elevated as it would 
have been expected due to an increase in Q˙  (Lodato et al., 1985) indicating 
pulmonary vasodilation. Alternatively, the ability of the pulmonary vasculature to 
accommodate the increases in cardiac output without increases in pressure 
could have been due to an increase in arterial compliance. We observed a lack 
of SPAP change when muscle mechanoreceptors were activated under 
conditions of basal pulmonary vascular tone in the control trial. The reason 
underpinning the latter observations might be related to the suggestion that at 
low (resting) tone the ability to dilate the pulmonary vasculature is very limited 
(Fishman, 1990).   
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The effects of atropine on the pulmonary vasculature were shown to depend on 
cardiac output and hence pulmonary blood flow (Chen et al., 1992; Murray et 
al., 1986). As such, Chen and co-workers (1992) observed in conscious dogs 
that the pulmonary pressure to flow ratio was not affected by atropine under 
conditions of low cardiac output but it was reduced under high cardiac output 
conditions. In support to our results have been studies showing that 
administration of atropine in humans induced increases in cardiac output that 
were accompanied by unchanged or mildly decreased pulmonary artery 
pressures (Daly et al., 1963; Williams et al., 1960). The effects of atropine on 
the pulmonary vasculature and haemodynamics have been also attributed to 
the inhibition of the M1 and/or M2 muscarinic receptors (El-Kashef et al., 1991; 
Wilson et al., 1992), which have been known to mediate the parasympathetic 
control of the pulmonary circulation in animals (Barnes & Liu, 1996) and 
humans (Norel et al.,1996; Walch et al., 2000).  
The SPAP response (~20% above baseline) that we have observed in response 
to isometric exercise of the calf isometric muscle was similar to that evidenced 
during handgrip exercise despite the existing differences in the duration and 
intensity and muscle group used among the exercise bouts (Chapter 1; Lykidis 
et al., 2008). These differences could underpin the larger increases in Q˙  and 
blood pressure we demonstrated during handgrip exercise as compared to 
these evidenced during calf exercise. The larger Q˙  response to exercise is due 
to the greater heart rate response seen during handgrip. The stroke volume 
response to exercise was similar amongst experiments.   
During circulatory occlusion following either handgrip or calf isometric exercise 
SPAP was maintained at the same levels (~15% above baseline). Similarly, the 
HR, SV and Q˙  responses to PECO were identical between experiments. Blood 
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pressure during PECO was maintained closely at levels seen during handgrip 
exercise whereas it was slightly reduced as compared to the values seen during 
calf exercise. The reasons underlying these differences could be related to 
sensitivity differences between muscle groups (Scott et al., 2002). The 
response of SV to PECO was similar amongst experiments.  
The heart rate and blood pressure responses that we observed in response to 
the activation of the muscle mechanoreflex by passive isometric stretch of the 
calf muscle, with and without concurrent metaboreflex activation, are 
comparable to these obtained by previous studies (Drew et al., 2008; 2009). We 
reported no changes in SV in response to the activation of muscle 
mechanoreceptors by passive isometric stretch. While to our knowledge the 
current investigation was the first to assess the SV response to static muscle 
stretching, studies that activated the muscle mechanoreflex in a dynamic 
fashion through passive cycling have produced mixed results with both 
unchanged (Nurhayati & Butcher, 1998) and slightly increased SV values 
(Vorluni & Volianitis, 2008) being reported.  
The interplay between the muscle metaboreflex and mechanoreflex has been 
widely accepted to play a large part in the mediation of cardiovascular control 
during exercise. Our findings suggest that interplay between the two reflexes 
could be also operative in controlling pulmonary haemodynamics and vascular 
resistance during exercise. Therefore the increases in pulmonary vascular 
pressure and resistance induced by the muscle metaboreflex could be offset by 
activation of mechanoreceptors during exercise resulting in the mediation of low 
pulmonary vascular resistance during exercise. This might contribute to the 
mediation of low PVR seen during dynamic exercise, since activation of the 
muscle mechanoreceptors by repetitive deformation of the mechanically 
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sensitive structures could represent a greater stimulus as compared to static 
stretching (Adreani et al., 1997; Pickar et al., 1994). 
On the contrary the mechanoreflex’ involvement in the mediation of abnormal 
pulmonary haemodynamics in CHF seems improbable, based on our present 
findings. The reason underpinning this postulation is that CHF is characterised 
by overactive mechanoreceptors, which would mediate pulmonary vasodilation 
and/or a reduction in PVR. However our findings could not be safely 
extrapolated to CHF patients given the health status of the subject cohort we 
used. 
In summary, the present data imply that the superimposition of muscle 
mechanoreflex activation on that of the muscle metaboreflex induced pulmonary 
vasodilation and/or increases in pulmonary arterial compliance. Our findings 
might be implicated in the regulation of pulmonary haemodynamics during 
exercise. 
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CHAPTER 7: 
GENERAL CONCLUSIONS 
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The control of pulmonary haemodynamics and ventilation during exercise is 
regulated by numerous factors. The interplay between these factors in the 
healthy state facilitates increases in breathing that are in accordance with the 
metabolic needs of the body, parallel to elevations in pulmonary blood flow 
under conditions of low PVR. The role of certain cardio-pulmonary reflex 
systems and/or their interaction in the mediation of these changes has not been 
clarified. Such information would be particularly beneficial in the understanding 
of the reduced exercise tolerance of patients with CHF, given that these reflex 
systems are deranged in this condition. 
The first study in this thesis assessed the pulmonary vascular response to the 
sustained activation of the muscle metaboreflex, induced by post-exercise 
circulatory occlusion in the active limb. It was demonstrated that the increases 
in SPAP induced by exercise were sustained during PECO. This, coupled to the 
drop of Q˙  towards resting levels seen during PECO suggests that the 
sympathoexcitation associated with the activation of the muscle metaboreflex 
induced pulmonary vasoconstriction and/or increases in PVR and arterial 
stiffness. Our findings uncovered a previously unknown aspect of pulmonary 
heamodynamics’ regulation and in fact could, but they could be also implicated 
in the reduced exercise capacity of CHF patients, given that the muscle 
metaboreflex is hyperactive in this condition. Moreover recent data evidenced 
reductions in metaboreflex activity and breathlessness during exercise along 
with improvements in pulmonary haemodynamics and in exercise ventilation 
after administration of sildenafil, which is known to improve systemic arterial 
function and blunt adrenergic stimulation (Guazzi et al., 2007; 2008). An 
extrapolation of our results in the findings of these investigations could suggest 
that the improvements seen in pulmonary vascular pressures and 
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breathlessness after sildenafil administration could have been at least partially 
accounted for by decreases in muscle metaboreflex activity.       
The second study of this thesis assessed the effect of hypermetabolism on the 
ventilatory chemosensitivity to inhaled CO2. We showed that mild increases in 
metabolic rate brought about by protein ingestion resulted in elevations in the 
ventilatory response to a hypercapnic ramp protocol. Although our 
methodological approach did not allow a comprehensive insight into the 
mechanisms responsible for our observations, careful consideration of the 
physiological responses associated to protein ingestion suggests that the 
effects of increased metabolism on ventilatory chemosensitivity could be at 
least partly attributed to an increased stimulation of the carotid body. Our 
findings could be implicated in the mechanisms responsible for the 
characteristic tight coupling of metabolic rate and ventilation seen at rest and 
during exercise.  
The third study of this thesis examined the ventilatory and cardiovascular 
responses to the combined activation of the muscle metaboreflex and the 
ventilatory chemoreflex, achieved by PECO and euoxic hypercapnia, 
respectively. We observed increases in respiraton during PECO in hypercapnia 
but not when breathing room air. The possible mediating mechanisms comprise 
decreases in cerebral blood flow and increases in carotid body stimulation due 
to PECO-associated sympathoexcitation. In addition, an interaction between the 
neural signals from muscle metaboreflex and the ventilatory chemoreflex at the 
level of the NTS might have augmented the medullary chemoreceptor input 
thereby increasing the chemosensitivity to CO2. The activation of the muscle 
metaboreflex accomplished against a background of activated chemoreceptors 
in this experiement could potentially resemble the interaction that takes place 
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between these reflexes during exercise in CHF. Therefore, the exercise-induced 
overactivation of the muscle metaboreflex in these patients could interact with 
their overactivated chemoreceptors resulting in abnormally greater ventilation 
related to the amount of CO2 that is produced metabolically.   
The fourth study of this thesis aimed to assess the pulmonary vascular 
response to the combined activation of the muscle metaboreflex and the muscle 
mechanoreflex, by PECO and static passive stretch of the calf muscle. It was 
shown that the elevation in SPAP due to calf isometric exercise was maintained 
during PECO, in agreement with the findings of first investigation in this thesis. 
During the subsequent stretch of the calf muscle, increases in SPAP were 
sustained while an increase in cardiac output was also observed. These data 
suggest that activation of the muscle mechanoreceptors under conditions of 
elevated pulmonary vascular tone/stiffness by muscle metaboreceptor 
activation mediates pulmonary vasodilation and/or increase in arterial 
compliance. Our findings provide information regarding a previously unknown 
aspect of pulmonary vascular regulation during exercise. 
The work in this thesis enhanced current knowledge on the regulation of 
pulmonary blood flow and ventilation during exercise. Activation of the muscle 
metaboreflex alone appeared to induce pulmonary vasoconstriction without 
having an influence on ventilation. Interestingly, the vasoconstrictive influence 
of the muscle metaboreflex was shown to be attenuated by the concurrent 
activation of the muscle mechanoreflex. In addition, when the muscle 
metaboreflex was activated against a background of activated ventilatory 
chemoreflex, a respiratory response was observed. In turn, the ventilatory 
response to the activation of the chemoreflex was enhanced under conditions of 
elevated metabolic rate. On the whole, the above findings further strengthen the 
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notion that the physiological control during exercise is the outcome of complex 
interaction between several systems and influences, whose isolated study could 
draw deficient, if not erroneous, conclusions. 
Findings from the first (Chapter 3), third (Chapter 5) and fourth (Chapter 6) 
studies in this thesis have potential implications in the reduced exercise 
tolerance of patients with CHF. However due to the fact that we used healthy 
young subjects whose physiological functioning is fundamentally different from 
that in CHF patients, our findings could not be safely extrapolated to that 
condition. Therefore the ventilatory, systemic and pulmonary haemodynamic, 
autonomic nervous system response to the activation of the muscle 
metaboreflex, with and without combined muscle mechanoreflex activation, 
could be studied in CHF patients and age-matched healthy controls under 
conditions of hypercapnia and during air breathing. These investigations could 
be conducted before and after a period of exercise training, given that the latter 
is known to induce beneficial changes in the ventilatory and cardiovascular 
control in CHF. Moreover, future studies could compare the contribution of the 
muscle metaboreflex and mechanoreflex activation to the pulmonary 
haemodynamic and ventilatory changes taking place during dynamic and 
isometric exercise. This can be also done under conditions of hypercapnia / air 
breathing in order to assess whether there is interplay between the associated 
reflexes in the mediation of the exercise response. In addition animal studies 
could provide insight on the central integration of neural signals from the muscle 
metaboreflex, the mechanoreflex and the ventilatory chemoreflex.  
An insight into the mechanisms responsible for the hypermetabolism-induced 
increases in the ventilatory chemosensitivity could be provided by incorporating 
cardiovascular data, body temperature, blood analyses for growth hormone, 
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potassium and acidity, and indices of ANS activation into the methodology. 
Neural blockade could be also employed so as to assess the influence of the 
autonomic nervous system in the effects of hypermetabolism on 
chemosensitivity. The above investigations could be also conducted on CHF 
patients, who are known to have increased levels of sympathetic nervous 
system activation, and their age-matched healthy controls.  
In summary, cardiovascular and respiratory reflex control systems appear to be 
involved in the control of the pulmonary blood flow and ventilation during 
exercise. Future studies are needed to examine the contribution of these 
systems in the reduced exercise tolerance in CHF patients.  
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